data_1f5y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f5y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.444 ' O ' HG21 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.457 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.816 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.469 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HZ2' ' HE1' ' A' ' 25' ' ' TRP . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.546 ' HE1' ' HZ2' ' A' ' 24' ' ' LYS . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 CA-C-O 119.478 -0.623 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.582 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.582 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.412 ' HB2' HG23 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 73' ' ' GLN . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 71' ' ' ASP . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' HG21 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.477 ' HB2' HD12 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.418 ' HB2' HD11 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 120.216 -0.214 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 55' ' ' SER . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 66' ' ' GLN . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.452 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.471 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.702 0 CA-C-O 119.726 -0.486 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.523 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.411 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.402 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.628 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.416 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.834 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.866 0 CA-C-O 119.958 -0.357 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.626 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.591 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.591 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.626 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.456 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.575 0 N-CA-C 113.559 0.183 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.425 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.413 HG11 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' HE2' ' A' ' 54' ' ' PHE . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.584 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.427 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.42 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.404 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.422 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 55' ' ' SER . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.524 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.48 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.407 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.06 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 73' ' ' GLN . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.43 ' HB2' HD12 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t . . . . . 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.087 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.177 0.989 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.433 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HE1' ' HZ3' ' A' ' 24' ' ' LYS . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.413 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 22' ' ' SER . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 79' ' ' GLY . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 tm0? -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.457 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.841 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.511 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.442 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.83 0 CA-C-O 120.023 -0.321 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.462 ' CD ' ' H ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.462 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 31' ' ' ALA . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.419 ' N ' ' HG ' ' A' ' 30' ' ' SER . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.154 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.646 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' NE ' ' HB3' ' A' ' 77' ' ' ASP . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.416 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.609 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.453 ' HB2' HD11 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.521 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.445 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.456 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.434 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.43 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.463 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' O ' HG21 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.404 ' HB2' HD11 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.412 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.9 m -143.9 -48.98 0.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.171 -0.515 . . . . 0.0 109.958 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.88 63.69 2.08 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.457 1.098 . . . . 0.0 111.667 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 5' ' ' GLY . 11.2 p 44.91 163.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 4' ' ' VAL . . . 155.72 -19.88 0.51 Allowed Glycine 0 N--CA 1.496 2.689 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.291 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.51 66.37 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.149 -1.025 . . . . 0.0 111.482 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -78.96 -176.74 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.458 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.17 165.32 12.67 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.9 pt-20 -148.75 42.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.891 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.74 -118.35 0.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.775 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.3 OUTLIER -102.25 6.18 40.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 -80.59 160.61 25.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.444 ' O ' HG21 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.457 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t -87.97 38.04 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 52.44 18.49 0.95 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.96 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -56.03 -37.48 69.27 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.774 0.797 . . . . 0.0 111.557 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.5 t -155.34 46.26 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.633 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.4 t -95.32 17.37 14.55 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.47 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 45' ' ' LEU . 4.8 mp -94.37 -23.27 17.86 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.226 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -101.17 -166.66 1.33 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.7 p 34.12 58.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.465 1.126 . . . . 0.0 111.519 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m 56.42 83.82 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.724 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.0 p -61.64 175.05 0.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.909 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -161.89 90.41 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.525 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -167.56 45.13 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.12 33.5 61.1 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.469 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -140.85 -48.22 0.42 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.54 31.55 0.67 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -69.42 158.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.133 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.7 51.64 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.73 140.67 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.048 . . . . 0.0 113.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -98.08 -158.8 0.69 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.536 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 58.9 m -144.21 175.06 10.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.406 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.63 43.94 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -119.92 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.16 7.61 46.02 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 -94.59 152.59 18.4 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HZ2' ' HE1' ' A' ' 25' ' ' TRP . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.546 ' HE1' ' HZ2' ' A' ' 24' ' ' LYS . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t -92.25 32.74 1.14 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 43.88 31.83 0.54 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.533 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -60.25 -37.02 79.09 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 t -145.48 40.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.57 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' ' 46' ' ' SER . 18.6 t -76.56 5.42 7.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.369 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 45' ' ' LEU . 2.1 mm? -78.26 29.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.38 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 44' ' ' CYS . 56.7 m -135.5 -102.14 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.27 139.67 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.419 ' H ' ' ND2' ' A' ' 61' ' ' ASN . 8.7 t 33.49 56.56 0.53 Allowed 'General case' 0 N--CA 1.505 2.315 0 O-C-N 124.719 1.262 . . . . 0.0 113.018 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.8 p -69.03 170.33 10.11 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.092 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -166.25 77.57 0.23 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.873 -1.967 . . . . 0.0 106.611 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 m -153.49 41.9 0.55 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.645 0.736 . . . . 0.0 111.649 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.93 2.57 39.06 Favored Glycine 0 N--CA 1.497 2.758 0 CA-C-N 114.757 -1.11 . . . . 0.0 114.504 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 48' ' ' THR . 6.0 t30 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.582 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.582 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.412 ' HB2' HG23 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 73' ' ' GLN . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 71' ' ' ASP . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.0 t 47.39 53.07 11.45 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.617 0.722 . . . . 0.0 110.239 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.89 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -46.63 154.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.663 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.05 10.6 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.22 89.17 2.53 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.279 -0.961 . . . . 0.0 111.224 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -81.11 -167.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.94 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.1 m -122.37 167.23 13.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.674 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -149.26 43.73 0.95 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.263 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -138.01 -118.84 0.14 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.655 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.6 p30 -98.85 1.26 45.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -82.45 157.79 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' HG21 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.477 ' HB2' HD12 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t -89.23 41.51 1.04 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 46.71 27.43 0.67 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.15 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.47 -32.75 70.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 t -152.73 22.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 112.495 -2.139 . . . . 0.0 110.754 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t -84.58 16.92 2.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' H ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.42 14.27 14.61 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.685 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.4 p -126.87 -86.32 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.828 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.69 112.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m 49.35 55.51 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.147 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.02 165.74 3.15 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.461 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -168.38 73.41 0.1 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.452 -1.703 . . . . 0.0 108.155 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -150.8 44.4 0.83 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.92 31.31 61.12 Favored Glycine 0 N--CA 1.498 2.807 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -170.74 0.83 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.099 0.529 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.77 46.77 26.09 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.562 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.61 120.85 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.4 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.7 -10.86 58.61 Favored Glycine 0 N--CA 1.498 2.813 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.684 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -74.39 -164.97 0.29 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.056 0.455 . . . . 0.0 111.843 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HD3' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -121.53 177.21 5.31 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.738 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.4 m -79.62 171.9 14.51 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.123 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -147.82 43.56 1.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.04 -117.14 0.14 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.952 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -104.83 9.18 34.92 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 -85.34 157.67 20.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.418 ' HB2' HD11 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t -91.18 35.38 0.92 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 44.96 20.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -57.43 -34.85 69.37 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 45' ' ' LEU . 8.2 t -136.35 28.09 3.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.642 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.7 t -86.49 23.34 1.64 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 43' ' ' THR . 6.0 mp -100.46 113.33 26.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.4 p 56.5 -166.88 0.12 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 126.446 2.341 . . . . 0.0 110.417 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p 38.38 78.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.472 1.13 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m 59.15 55.99 4.11 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.643 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.8 p -82.45 -83.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 51.48 89.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.112 0.882 . . . . 0.0 110.943 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -129.6 30.47 4.91 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.134 0.968 . . . . 0.0 110.425 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.48 -7.18 5.15 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.96 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 55' ' ' SER . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 66' ' ' GLN . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -72.03 89.95 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.204 0.591 . . . . 0.0 110.134 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.119 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.43 -175.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.16 43.5 5.3 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.7 122.8 24.53 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -96.42 179.35 5.05 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.282 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.7 m -97.22 159.54 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.62 22.78 0.15 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.445 1.116 . . . . 0.0 113.011 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.0 -114.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.323 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -114.35 20.21 15.66 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.669 0.388 . . . . 0.0 111.921 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 -95.61 162.87 13.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.452 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.471 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t -90.13 24.87 2.34 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 63.72 4.18 1.79 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.18 -30.94 1.29 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 120.579 1.536 . . . . 0.0 114.848 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 t -149.55 49.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.305 1.003 . . . . 0.0 112.539 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 t -81.46 -3.86 54.19 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.307 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.3 mm? -82.37 -7.04 59.63 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.223 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.5 m -100.3 169.56 9.04 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.634 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p 34.13 97.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 124.972 1.42 . . . . 0.0 114.085 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 t 41.81 60.76 2.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 123.178 1.466 . . . . 0.0 111.009 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.6 p -49.81 168.52 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 112.455 -2.157 . . . . 0.0 114.381 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -147.39 82.97 1.54 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.252 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 p -164.37 37.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.87 23.91 57.05 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.781 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.523 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.411 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.402 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.628 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -158.83 -57.43 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.81 152.54 24.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.966 0.791 . . . . 0.0 111.226 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.86 169.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.797 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.56 -52.64 1.41 Allowed Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.956 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.4 t70 59.33 5.0 0.54 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -89.0 -177.21 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.524 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 42.9 m -129.39 175.7 8.55 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.45 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.79 47.46 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.04 -120.22 0.11 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.53 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 11' ' ' ASN . 3.0 p30 -104.11 3.51 33.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 -81.63 156.58 25.06 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.416 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t -88.08 30.92 0.82 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 47.25 18.89 0.1 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.219 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -54.03 -35.05 61.53 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.032 0.92 . . . . 0.0 110.541 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.472 ' HG1' ' H ' ' A' ' 44' ' ' CYS . 4.2 t -124.82 -124.01 0.25 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.472 ' H ' ' HG1' ' A' ' 43' ' ' THR . 12.0 t 82.61 -4.58 1.36 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.025 2.13 . . . . 0.0 114.132 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 45' ' ' LEU . 2.8 mm? -79.0 35.36 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.027 0.441 . . . . 0.0 111.898 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.0 m -144.18 -62.44 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.01 80.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.157 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m 50.8 81.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.593 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 p -65.56 -169.95 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.621 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -169.62 84.83 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 t -153.51 42.89 0.58 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.083 0.944 . . . . 0.0 110.478 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.05 4.72 23.04 Favored Glycine 0 N--CA 1.499 2.834 0 CA-C-N 114.39 -1.277 . . . . 0.0 115.121 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -65.37 148.62 51.4 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.98 0.459 . . . . 0.0 111.089 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.68 170.29 19.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.953 0.783 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.99 165.56 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.596 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.61 -35.02 4.5 Favored Glycine 0 N--CA 1.497 2.706 0 CA-C-N 113.099 -1.864 . . . . 0.0 110.604 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.6 73.41 10.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.534 1.159 . . . . 0.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -101.72 -179.04 3.9 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.442 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.37 169.92 17.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.01 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.5 47.19 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.43 -120.08 0.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.872 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.41 4.25 50.69 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 -88.75 153.89 20.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t -89.99 42.83 1.11 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.612 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 48.8 mt-30 51.34 16.35 0.4 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -57.81 -36.5 72.3 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.456 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 45' ' ' LEU . 7.0 t -144.18 34.2 1.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.391 -1.732 . . . . 0.0 112.811 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 41' ' ' GLN . 40.8 m -78.78 16.44 0.87 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.803 . . . . 0.0 110.828 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.4 mm? -98.38 -27.86 13.9 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.6 p -110.23 -179.17 3.7 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.338 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 32.33 87.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 124.787 1.304 . . . . 0.0 113.551 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m 54.44 68.97 0.77 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -55.34 176.46 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.928 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -165.72 87.27 0.38 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.598 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 p -164.52 41.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.32 65.79 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.785 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.626 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.591 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.591 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.626 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -145.06 150.52 37.0 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.143 0.555 . . . . 0.0 109.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.89 70.31 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.373 1.045 . . . . 0.0 111.506 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.96 -34.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.44 44.45 0.71 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -76.12 17.56 0.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.498 -0.851 . . . . 0.0 113.256 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -79.21 175.31 10.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.272 0.558 . . . . 0.0 111.955 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.31 176.37 5.93 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.978 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.9 43.79 0.98 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.75 -118.29 0.12 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.897 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.83 4.84 38.24 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 -79.33 158.17 27.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.456 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t -85.72 37.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 34.46 56.88 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -96.92 -43.68 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 t -135.08 36.63 3.03 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.885 -1.961 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 49' ' ' CYS . 16.4 t -98.89 37.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.02 8.04 3.46 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 111.69 -2.505 . . . . 0.0 110.585 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.8 m -134.47 -159.05 0.93 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t 60.99 -78.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 124.283 0.989 . . . . 0.0 110.364 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.8 m -141.83 42.69 1.7 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 44' ' ' CYS . 46.9 t -150.87 175.48 11.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.475 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 40.2 ttmt -150.76 120.49 7.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p 39.14 33.24 0.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.508 1.13 . . . . 0.0 113.977 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.34 56.07 8.44 Favored Glycine 0 N--CA 1.495 2.575 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.559 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.425 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.413 HG11 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' HE2' ' A' ' 54' ' ' PHE . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.584 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -153.73 155.99 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.0 164.29 36.76 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.537 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.62 166.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.41 -38.15 0.14 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.25 97.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.045 -1.078 . . . . 0.0 111.458 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -80.01 -178.93 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.196 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 98.0 m -100.1 174.22 6.26 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.455 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 11.1 pt-20 -157.4 46.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.234 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.51 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -146.35 -122.07 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.424 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.7 p30 -97.86 3.22 49.83 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 -78.98 157.97 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.42 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t -88.33 36.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 51.99 19.09 0.92 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.974 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.63 -36.29 69.29 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.448 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -139.9 -122.63 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 31.9 t 64.88 30.38 12.08 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.202 1.001 . . . . 0.0 113.661 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.89 89.53 5.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' THR . 34.9 t 53.5 37.85 26.69 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.472 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 p 55.65 -21.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 C-N-CA 128.593 2.757 . . . . 0.0 115.072 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' SER . 59.9 p -89.25 42.07 1.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 55' ' ' SER . 28.3 p 43.4 -174.07 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 52' ' ' GLY . 86.4 tttt -37.14 133.32 0.66 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.6 t -89.7 31.88 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.734 1.254 . . . . 0.0 108.751 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -126.94 -38.26 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -143.62 125.48 15.18 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 178.07 9.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.005 0.816 . . . . 0.0 110.252 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.89 -35.3 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.859 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.42 23.67 77.34 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.313 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.6 148.66 51.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.985 0.462 . . . . 0.0 111.354 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -79.74 179.57 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.621 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . 68.0 m -94.99 179.69 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.639 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -158.35 49.93 0.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.4 -122.15 0.1 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.1 p30 -98.82 -0.91 41.57 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 -79.56 154.51 28.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.422 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t -89.85 34.16 0.85 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 44.54 29.81 0.44 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.3 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -58.09 -37.86 75.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.553 1.168 . . . . 0.0 108.334 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 44' ' ' CYS . 1.6 t -126.23 -100.78 0.37 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.6 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.508 ' H ' HG22 ' A' ' 43' ' ' THR . 9.8 t 63.31 48.31 3.66 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.974 1.309 . . . . 0.0 108.714 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.55 -22.88 9.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.792 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -85.93 -100.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.52 147.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 123.091 0.244 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t 34.42 49.11 0.32 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 124.836 1.335 . . . . 0.0 112.623 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 p -63.02 168.13 4.29 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.893 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HE3' ' SG ' ' A' ' 44' ' ' CYS . 18.4 ptpt -131.42 -154.98 0.66 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.074 -1.875 . . . . 0.0 110.379 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.8 t 63.74 41.91 6.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.5 1.125 . . . . 0.0 111.433 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.16 22.76 0.57 Allowed Glycine 0 N--CA 1.5 2.926 0 CA-C-N 113.344 -1.753 . . . . 0.0 117.14 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 55' ' ' SER . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.48 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -140.6 44.59 1.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.418 0.627 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.16 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.23 150.11 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.721 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.33 41.2 99.45 Favored Glycine 0 N--CA 1.498 2.782 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.342 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.72 129.86 40.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -87.12 -175.82 5.47 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.8 m -142.6 168.35 19.93 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.851 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.54 44.72 0.7 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.814 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.69 -121.68 0.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.418 HD21 ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -92.8 5.59 50.64 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 -98.63 146.73 25.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HB2' HD12 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.407 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t -87.67 31.09 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 51.48 10.14 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.623 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -49.37 -34.93 17.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 t -151.0 51.04 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.612 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.5 t -80.94 -6.05 58.23 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 45' ' ' LEU . 2.6 mm? -79.11 -36.2 41.03 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 123.86 0.725 . . . . 0.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -68.2 -179.31 1.23 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.146 0.904 . . . . 0.0 111.678 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 p 36.17 47.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 124.925 1.391 . . . . 0.0 112.291 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.5 m 53.7 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 53' ' ' ASP . 30.1 p -46.34 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.356 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 4.4 ttmp? -151.0 63.5 0.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.212 -1.813 . . . . 0.0 106.842 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.3 t -152.48 50.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.891 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.77 22.4 Favored Glycine 0 N--CA 1.502 3.06 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.775 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.55 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 73' ' ' GLN . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 49.06 42.66 21.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.42 0.718 . . . . 0.0 111.989 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.23 91.84 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.417 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t 61.04 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.039 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.58 -73.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -117.77 88.84 2.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -97.96 -175.68 3.22 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.111 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -108.47 176.0 5.27 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.455 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.4 pt-20 -147.35 42.82 1.1 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.33 -117.78 0.11 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.73 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -107.9 15.03 24.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 -86.3 161.93 18.5 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.43 ' HB2' HD12 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t -90.06 40.3 1.0 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 36.44 31.81 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -61.06 -37.14 81.59 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -124.96 -146.51 0.35 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.6 t 45.65 20.27 0.06 Allowed 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 122.065 0.935 . . . . 0.0 111.752 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.4 tp -163.51 -53.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.088 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -87.18 62.03 7.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.536 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -170.46 174.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 112.701 -2.045 . . . . 0.0 105.572 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -70.01 74.74 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.492 0.663 . . . . 0.0 110.02 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.8 m -154.52 168.62 26.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.919 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 51' ' ' SER . 3.4 tmmm? -141.14 152.17 44.49 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.432 ' N ' ' HD2' ' A' ' 50' ' ' LYS . 80.2 p -82.54 25.98 0.6 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.27 -8.79 0.33 Allowed Glycine 0 N--CA 1.502 3.087 0 CA-C-N 113.679 -1.601 . . . . 0.0 113.55 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m 54.53 -151.0 0.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.35 0.676 . . . . 0.0 111.349 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.76 63.19 2.33 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.756 0.788 . . . . 0.0 111.814 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.73 -34.84 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.19 59.95 2.09 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 123.721 0.638 . . . . 0.0 113.432 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 72.71 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.53 0.681 . . . . 0.0 110.418 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -94.08 167.21 11.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.38 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.7 m -125.4 171.46 10.43 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.753 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.53 41.88 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.2 -117.86 0.12 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.844 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.35 11.52 20.04 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 -78.31 161.07 27.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.652 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.433 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HE1' ' HZ3' ' A' ' 24' ' ' LYS . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.413 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t -90.28 30.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 43.05 36.28 0.9 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.344 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.62 -45.52 92.46 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 t -114.14 -119.33 0.31 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 112.499 -2.137 . . . . 0.0 106.561 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t 64.56 43.72 4.29 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.884 1.274 . . . . 0.0 111.987 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 45' ' ' LEU . 3.0 mm? -85.69 68.12 10.29 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' THR . 40.2 t 60.05 88.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.361 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 48' ' ' THR . 7.7 p 38.36 -60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.641 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 ' H ' HG12 ' A' ' 47' ' ' VAL . 34.6 p -76.8 49.56 0.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 111.554 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.5 p 37.46 -153.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.392 1.477 . . . . 0.0 113.207 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 52' ' ' GLY . 87.7 tttt -51.52 139.26 20.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.4 t -88.25 31.85 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.158 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -117.95 -34.07 1.19 Allowed Glycine 0 N--CA 1.495 2.594 0 CA-C-N 112.615 -2.084 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 156.22 46.42 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.885 -0.658 . . . . 0.0 109.567 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.79 86.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.534 1.147 . . . . 0.0 111.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.69 -163.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.379 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.58 28.43 72.29 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.5 85.3 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.576 0.703 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -92.44 168.27 11.39 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.724 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.5 m -139.94 173.45 11.51 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.468 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.09 43.91 1.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -118.78 0.12 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.94 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -102.79 2.08 35.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 -79.38 154.9 28.67 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 22' ' ' SER . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 41' ' ' GLN . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t -86.43 29.12 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 39' ' ' GLU . 36.8 tt0 38.98 37.74 0.24 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.056 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.36 -46.42 90.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -107.09 -127.81 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.169 -2.159 . . . . 0.0 105.169 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t 62.95 28.7 16.4 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.741 1.217 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.83 90.34 4.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.3 m 66.5 -76.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.389 1.68 . . . . 0.0 108.088 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -171.94 -28.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.2 p -81.96 34.7 0.41 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.455 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p 37.29 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 52' ' ' GLY . 28.9 mtpp -29.72 123.7 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.579 1.174 . . . . 0.0 112.668 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -82.62 27.44 0.52 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -124.92 -33.02 0.76 Allowed Glycine 0 N--CA 1.495 2.606 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 79' ' ' GLY . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -70.1 158.81 35.05 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.947 0.44 . . . . 0.0 110.618 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.11 147.81 27.53 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.64 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 5' ' ' GLY . 9.7 p 32.95 -119.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.98 1.425 . . . . 0.0 113.376 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.407 ' H ' HG13 ' A' ' 4' ' ' VAL . . . 93.94 -23.76 29.61 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -133.08 78.24 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.392 0.615 . . . . 0.0 111.59 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -95.0 176.62 6.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.6 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 92.2 m -90.11 172.73 8.61 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.577 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.48 45.07 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -142.09 -117.97 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.076 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.36 10.79 27.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 -79.1 156.19 28.42 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 tm0? -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.457 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t -87.65 40.21 0.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 50.8 21.95 1.04 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.34 -37.3 85.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.004 0.907 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -152.2 30.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.661 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -92.64 25.56 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.274 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.76 -32.39 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.149 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -100.93 -177.06 3.35 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.489 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 34.17 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p 33.43 48.5 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.706 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p -40.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.517 -2.129 . . . . 0.0 116.09 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 52.63 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.895 0.747 . . . . 0.0 111.295 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -146.59 34.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.016 0.912 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.49 2.64 69.13 Favored Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.949 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.511 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.442 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -63.76 -36.82 85.13 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.028 0.487 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.33 53.22 12.24 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.449 1.093 . . . . 0.0 112.298 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -73.73 162.5 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.755 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.43 -9.37 61.21 Favored Glycine 0 N--CA 1.498 2.827 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.237 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 134.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -97.89 168.46 10.29 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.651 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.6 m -134.0 168.19 19.25 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.773 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.8 pt-20 -145.87 42.09 1.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.845 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.81 -119.59 0.15 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.314 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.53 16.71 22.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 -105.47 152.49 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t -89.35 28.91 1.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 46.38 28.8 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.88 -31.35 66.64 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 45' ' ' LEU . 3.1 t -129.67 -120.71 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 111.125 -2.761 . . . . 0.0 105.039 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 t 82.17 -22.85 0.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.575 1.95 . . . . 0.0 109.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -78.92 20.08 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.771 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.9 m -103.25 -61.57 1.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.85 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 124.314 1.009 . . . . 0.0 113.322 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.1 m 47.96 36.3 6.03 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.72 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.4 m -130.11 163.08 27.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.385 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.85 32.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p 43.11 37.07 1.07 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.548 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.48 15.57 0.32 Allowed Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.68 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 m -67.9 123.52 20.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.039 0.493 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.88 87.49 5.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.031 0.832 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.61 -169.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.707 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.11 36.45 91.92 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 53.27 89.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.904 1.002 . . . . 0.0 113.326 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -79.79 179.18 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.795 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.73 161.19 21.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.9 pt-20 -160.69 23.7 0.15 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.082 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HD2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -145.66 -116.86 0.08 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.057 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.78 8.6 24.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 -78.97 159.06 27.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.462 ' HB2' HD12 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 31' ' ' ALA . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.419 ' N ' ' HG ' ' A' ' 30' ' ' SER . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t -93.98 36.8 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 60.28 -11.37 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -44.35 -33.43 1.63 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 121.05 1.75 . . . . 0.0 112.277 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.2 p -102.68 -121.21 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.062 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t 57.78 23.24 9.36 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.457 1.903 . . . . 0.0 110.394 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 49' ' ' CYS . 67.6 mt -79.53 -79.81 0.13 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.446 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m 37.6 -103.91 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 HG21 ' H ' ' A' ' 48' ' ' THR . 17.7 m -49.44 -104.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.169 0.987 . . . . 0.0 113.525 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.466 ' H ' HG21 ' A' ' 47' ' ' VAL . 4.9 t -84.57 62.25 7.18 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 55' ' ' SER . 24.5 p -55.15 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 53.11 23.28 2.94 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 123.646 1.689 . . . . 0.0 109.086 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.1 t 60.21 61.81 1.74 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 111.55 -2.568 . . . . 0.0 114.557 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.08 34.71 2.1 Favored Glycine 0 N--CA 1.503 3.154 0 CA-C-N 113.068 -1.878 . . . . 0.0 116.683 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.646 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.606 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' NE ' ' HB3' ' A' ' 77' ' ' ASP . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.416 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.609 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -72.78 96.0 1.99 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.161 -0.52 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.04 56.05 7.27 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.529 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.08 150.41 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.304 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.83 -13.04 3.91 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.24 36.18 0.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.451 -0.874 . . . . 0.0 111.297 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -93.68 -167.99 1.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.721 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.9 m -145.69 173.91 11.66 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.26 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.27 45.32 0.97 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.5 -118.75 0.11 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.219 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.74 5.48 36.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 -82.76 156.82 23.51 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' CD1' HG23 ' A' ' 43' ' ' THR . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.453 ' HB2' HD11 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t -96.52 34.67 1.6 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 29.66 57.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.399 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -85.42 -37.62 19.59 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.249 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.452 HG23 ' CD1' ' A' ' 13' ' ' PHE . 5.6 t -122.5 -6.73 8.68 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.785 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 28.9 t -63.25 -5.47 3.4 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.313 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -83.38 31.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.778 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.9 m -142.89 -65.45 0.39 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.98 84.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 124.347 1.029 . . . . 0.0 110.361 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m 49.9 69.03 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.2 167.21 6.87 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.754 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -170.26 90.26 0.17 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.789 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -162.36 52.62 0.21 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.65 32.09 58.19 Favored Glycine 0 N--CA 1.498 2.798 0 CA-C-N 113.459 -1.7 . . . . 0.0 113.386 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.521 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.445 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 m -72.6 94.82 1.76 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.129 0.546 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.92 2.84 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.14 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.6 173.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.76 37.44 34.18 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.29 109.1 5.1 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.376 0.608 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -103.45 -170.33 1.77 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.235 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -119.86 172.02 8.01 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.883 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' H ' ' NH1' ' A' ' 10' ' ' ARG . 11.2 pt-20 -145.77 42.47 1.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -137.92 -118.18 0.15 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.229 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.99 11.27 35.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 -90.16 156.93 18.0 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.456 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t -86.17 38.97 0.79 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 42.45 24.31 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.21 -40.57 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 t -148.02 89.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.008 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -125.68 1.14 7.5 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.139 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 45' ' ' LEU . 2.4 mm? -78.8 -19.42 52.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.862 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -65.9 158.01 29.11 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.92 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG21 ' H ' ' A' ' 48' ' ' THR . 11.2 p 37.67 -123.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 124.762 1.289 . . . . 0.0 111.644 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.417 ' H ' HG21 ' A' ' 47' ' ' VAL . 98.4 m -92.36 101.92 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.64 -172.75 1.96 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.176 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -168.02 76.1 0.13 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -149.94 40.23 0.8 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.911 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.86 5.27 3.95 Favored Glycine 0 N--CA 1.501 3.008 0 CA-C-N 114.407 -1.269 . . . . 0.0 115.779 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.434 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.43 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.463 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.0 m -69.45 136.09 51.07 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.913 0.419 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.87 157.83 35.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.976 0.797 . . . . 0.0 110.638 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.64 179.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.926 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.46 -0.66 47.82 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.85 70.96 9.95 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.668 -0.766 . . . . 0.0 110.843 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -78.59 176.2 9.67 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.585 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.52 175.86 5.98 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.0 pt-20 -148.06 43.44 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.53 -118.01 0.13 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.626 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.47 1.38 41.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -79.47 157.88 27.39 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' O ' HG21 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' HB2' HD11 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t -88.63 29.46 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 68.37 -0.25 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.46 -30.78 1.49 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -151.63 32.42 0.56 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.56 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.9 t -89.34 22.18 3.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.049 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 45' ' ' LEU . 5.2 mp -105.2 -31.16 9.25 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.612 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.469 ' HG ' ' H ' ' A' ' 47' ' ' VAL . 65.8 p -88.73 -112.31 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.607 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' H ' ' HG ' ' A' ' 46' ' ' SER . 12.0 p -50.84 139.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.227 0.329 . . . . 0.0 111.687 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t 35.1 46.95 0.25 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 125.033 1.458 . . . . 0.0 113.095 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.4 p -58.4 165.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.982 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -164.13 88.83 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.998 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -171.66 49.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.91 35.86 64.87 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.412 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.816 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CZ ' ' H ' ' A' ' 63' ' ' CYS . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.477 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 22' ' ' SER . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.558 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 CA-C-O 119.478 -0.623 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.618 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.563 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 61' ' ' ASN . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 60' ' ' VAL . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.505 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 120.216 -0.214 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 76' ' ' CYS . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 54' ' ' PHE . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.518 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.587 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.702 0 CA-C-O 119.726 -0.486 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.69 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.552 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 23' ' ' TYR . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.834 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HE ' ' HG3' ' A' ' 66' ' ' GLN . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HA ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.506 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.866 0 CA-C-O 119.958 -0.357 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.627 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.414 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.682 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.554 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.575 0 N-CA-C 113.559 0.183 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 76' ' ' CYS . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 59' ' ' ARG . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HA ' HG22 ' A' ' 26' ' ' VAL . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 23' ' ' TYR . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.552 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HG3' HG22 ' A' ' 60' ' ' VAL . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 59' ' ' ARG . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 82' ' ' GLU . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 26' ' ' VAL . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 23' ' ' TYR . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.482 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.638 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.568 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.06 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.522 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 59' ' ' ARG . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.502 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.538 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 23' ' ' TYR . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t . . . . . 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.087 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.177 0.989 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' O ' HG22 ' A' ' 26' ' ' VAL . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.564 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 68' ' ' TRP . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.413 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.479 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 23' ' ' TYR . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.417 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' HB3' HD12 ' A' ' 64' ' ' ILE . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.552 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.841 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 63' ' ' CYS . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG3' HG22 ' A' ' 60' ' ' VAL . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.567 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 79' ' ' GLY . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.576 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.83 0 CA-C-O 120.023 -0.321 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' HA ' HG22 ' A' ' 26' ' ' VAL . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.569 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 21' ' ' ILE . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.154 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.675 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.4 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 23' ' ' TYR . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.556 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 64' ' ' ILE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.56 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.523 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 82' ' ' GLU . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' HA2' ' A' ' 79' ' ' GLY . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 60' ' ' VAL . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.427 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.9 m -143.9 -48.98 0.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.171 -0.515 . . . . 0.0 109.958 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.88 63.69 2.08 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.457 1.098 . . . . 0.0 111.667 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 5' ' ' GLY . 11.2 p 44.91 163.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.456 ' N ' HG22 ' A' ' 4' ' ' VAL . . . 155.72 -19.88 0.51 Allowed Glycine 0 N--CA 1.496 2.689 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.291 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.51 66.37 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.149 -1.025 . . . . 0.0 111.482 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -78.96 -176.74 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.458 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.17 165.32 12.67 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.9 pt-20 -148.75 42.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.891 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HD2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -136.74 -118.35 0.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.775 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -102.25 6.18 40.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 -80.59 160.61 25.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t -87.97 38.04 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 52.44 18.49 0.95 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.96 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -56.03 -37.48 69.27 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.774 0.797 . . . . 0.0 111.557 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.5 t -155.34 46.26 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.633 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.4 t -95.32 17.37 14.55 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.47 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.8 mp -94.37 -23.27 17.86 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.226 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -101.17 -166.66 1.33 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.7 p 34.12 58.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.465 1.126 . . . . 0.0 111.519 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m 56.42 83.82 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.724 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.0 p -61.64 175.05 0.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.909 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -161.89 90.41 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.525 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -167.56 45.13 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.12 33.5 61.1 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CZ ' ' H ' ' A' ' 63' ' ' CYS . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.477 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -140.85 -48.22 0.42 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.54 31.55 0.67 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -69.42 158.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.133 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.7 51.64 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.73 140.67 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.048 . . . . 0.0 113.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -98.08 -158.8 0.69 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.536 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 58.9 m -144.21 175.06 10.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.406 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.63 43.94 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -119.92 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -98.16 7.61 46.02 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 -94.59 152.59 18.4 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 43' ' ' THR . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 22' ' ' SER . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.558 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t -92.25 32.74 1.14 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 43.88 31.83 0.54 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.533 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -60.25 -37.02 79.09 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 13' ' ' PHE . 5.4 t -145.48 40.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.57 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 46' ' ' SER . 18.6 t -76.56 5.42 7.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.369 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.509 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.1 mm? -78.26 29.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.38 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 44' ' ' CYS . 56.7 m -135.5 -102.14 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.27 139.67 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 t 33.49 56.56 0.53 Allowed 'General case' 0 N--CA 1.505 2.315 0 O-C-N 124.719 1.262 . . . . 0.0 113.018 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.8 p -69.03 170.33 10.11 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.092 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -166.25 77.57 0.23 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.873 -1.967 . . . . 0.0 106.611 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 m -153.49 41.9 0.55 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.645 0.736 . . . . 0.0 111.649 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.93 2.57 39.06 Favored Glycine 0 N--CA 1.497 2.758 0 CA-C-N 114.757 -1.11 . . . . 0.0 114.504 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.618 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.0 t 47.39 53.07 11.45 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.617 0.722 . . . . 0.0 110.239 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.89 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -46.63 154.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.663 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.05 10.6 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.22 89.17 2.53 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.279 -0.961 . . . . 0.0 111.224 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -81.11 -167.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.94 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 77.1 m -122.37 167.23 13.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.674 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -149.26 43.73 0.95 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.263 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -138.01 -118.84 0.14 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.655 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -98.85 1.26 45.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -82.45 157.79 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.563 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t -89.23 41.51 1.04 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 46.71 27.43 0.67 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.15 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.47 -32.75 70.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 t -152.73 22.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 112.495 -2.139 . . . . 0.0 110.754 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t -84.58 16.92 2.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.506 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.42 14.27 14.61 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.685 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.4 p -126.87 -86.32 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.828 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.69 112.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m 49.35 55.51 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.147 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.02 165.74 3.15 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.461 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -168.38 73.41 0.1 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.452 -1.703 . . . . 0.0 108.155 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -150.8 44.4 0.83 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.92 31.31 61.12 Favored Glycine 0 N--CA 1.498 2.807 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 61' ' ' ASN . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 60' ' ' VAL . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -170.74 0.83 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.099 0.529 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.77 46.77 26.09 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.562 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.61 120.85 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.4 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.7 -10.86 58.61 Favored Glycine 0 N--CA 1.498 2.813 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.684 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -74.39 -164.97 0.29 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.056 0.455 . . . . 0.0 111.843 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -121.53 177.21 5.31 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.738 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.4 m -79.62 171.9 14.51 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.123 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -147.82 43.56 1.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.04 -117.14 0.14 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.952 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -104.83 9.18 34.92 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 -85.34 157.67 20.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 43' ' ' THR . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.505 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t -91.18 35.38 0.92 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.96 20.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -57.43 -34.85 69.37 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 45' ' ' LEU . 8.2 t -136.35 28.09 3.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.642 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.7 t -86.49 23.34 1.64 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -100.46 113.33 26.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.4 p 56.5 -166.88 0.12 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 126.446 2.341 . . . . 0.0 110.417 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p 38.38 78.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.472 1.13 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m 59.15 55.99 4.11 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.643 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.8 p -82.45 -83.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 51.48 89.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.112 0.882 . . . . 0.0 110.943 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -129.6 30.47 4.91 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.134 0.968 . . . . 0.0 110.425 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.48 -7.18 5.15 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.96 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 76' ' ' CYS . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 54' ' ' PHE . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.518 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -72.03 89.95 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.204 0.591 . . . . 0.0 110.134 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.119 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.43 -175.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.16 43.5 5.3 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.7 122.8 24.53 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -96.42 179.35 5.05 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.282 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.7 m -97.22 159.54 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 12.3 pt-20 -160.62 22.78 0.15 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.445 1.116 . . . . 0.0 113.011 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.0 -114.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.323 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -114.35 20.21 15.66 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.669 0.388 . . . . 0.0 111.921 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 -95.61 162.87 13.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.587 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t -90.13 24.87 2.34 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 63.72 4.18 1.79 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.18 -30.94 1.29 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 120.579 1.536 . . . . 0.0 114.848 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 t -149.55 49.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.305 1.003 . . . . 0.0 112.539 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 t -81.46 -3.86 54.19 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.307 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.3 mm? -82.37 -7.04 59.63 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.223 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.5 m -100.3 169.56 9.04 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.634 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p 34.13 97.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 124.972 1.42 . . . . 0.0 114.085 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 t 41.81 60.76 2.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 123.178 1.466 . . . . 0.0 111.009 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.6 p -49.81 168.52 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 112.455 -2.157 . . . . 0.0 114.381 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -147.39 82.97 1.54 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.252 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 p -164.37 37.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.87 23.91 57.05 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.781 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.69 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.552 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -158.83 -57.43 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.81 152.54 24.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.966 0.791 . . . . 0.0 111.226 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.86 169.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.797 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.56 -52.64 1.41 Allowed Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.956 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.4 t70 59.33 5.0 0.54 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -89.0 -177.21 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.524 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 42.9 m -129.39 175.7 8.55 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.45 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.79 47.46 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.04 -120.22 0.11 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.53 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 8.7 p-10 -104.11 3.51 33.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 -81.63 156.58 25.06 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 23' ' ' TYR . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t -88.08 30.92 0.82 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 63.2 tt0 47.25 18.89 0.1 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.219 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -54.03 -35.05 61.53 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.032 0.92 . . . . 0.0 110.541 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -124.82 -124.01 0.25 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 t 82.61 -4.58 1.36 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.025 2.13 . . . . 0.0 114.132 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.8 mm? -79.0 35.36 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.027 0.441 . . . . 0.0 111.898 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.0 m -144.18 -62.44 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.01 80.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.157 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m 50.8 81.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.593 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 p -65.56 -169.95 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.621 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -169.62 84.83 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 t -153.51 42.89 0.58 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.083 0.944 . . . . 0.0 110.478 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.05 4.72 23.04 Favored Glycine 0 N--CA 1.499 2.834 0 CA-C-N 114.39 -1.277 . . . . 0.0 115.121 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HE ' ' HG3' ' A' ' 66' ' ' GLN . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -65.37 148.62 51.4 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.98 0.459 . . . . 0.0 111.089 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.68 170.29 19.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.953 0.783 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 5' ' ' GLY . 7.3 p -157.99 165.56 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.596 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 4' ' ' VAL . . . 115.61 -35.02 4.5 Favored Glycine 0 N--CA 1.497 2.706 0 CA-C-N 113.099 -1.864 . . . . 0.0 110.604 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.6 73.41 10.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.534 1.159 . . . . 0.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -101.72 -179.04 3.9 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.442 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.37 169.92 17.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.01 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.0 pt-20 -155.5 47.19 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.43 -120.08 0.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.872 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -97.41 4.25 50.69 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 -88.75 153.89 20.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HA ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.506 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t -89.99 42.83 1.11 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.624 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 48.8 mt-30 51.34 16.35 0.4 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -57.81 -36.5 72.3 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.456 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' LEU . 7.0 t -144.18 34.2 1.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.391 -1.732 . . . . 0.0 112.811 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 41' ' ' GLN . 40.8 m -78.78 16.44 0.87 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.803 . . . . 0.0 110.828 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.4 mm? -98.38 -27.86 13.9 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.6 p -110.23 -179.17 3.7 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.338 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 32.33 87.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 124.787 1.304 . . . . 0.0 113.551 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.481 ' HA ' HD22 ' A' ' 61' ' ' ASN . 96.1 m 54.44 68.97 0.77 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -55.34 176.46 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.928 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -165.72 87.27 0.38 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.598 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 p -164.52 41.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.32 65.79 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.785 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.481 HD22 ' HA ' ' A' ' 48' ' ' THR . 28.5 t-20 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.627 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.414 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.682 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -145.06 150.52 37.0 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.143 0.555 . . . . 0.0 109.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.89 70.31 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.373 1.045 . . . . 0.0 111.506 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.96 -34.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.44 44.45 0.71 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -76.12 17.56 0.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.498 -0.851 . . . . 0.0 113.256 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -79.21 175.31 10.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.272 0.558 . . . . 0.0 111.955 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.31 176.37 5.93 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.978 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.4 pt-20 -148.9 43.79 0.98 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.75 -118.29 0.12 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.897 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -102.83 4.84 38.24 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 -79.33 158.17 27.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.554 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t -85.72 37.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 34.46 56.88 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -96.92 -43.68 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 t -135.08 36.63 3.03 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.885 -1.961 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 49' ' ' CYS . 16.4 t -98.89 37.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.02 8.04 3.46 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 111.69 -2.505 . . . . 0.0 110.585 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.8 m -134.47 -159.05 0.93 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t 60.99 -78.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 124.283 0.989 . . . . 0.0 110.364 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.8 m -141.83 42.69 1.7 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 46.9 t -150.87 175.48 11.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.475 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 40.2 ttmt -150.76 120.49 7.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p 39.14 33.24 0.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.508 1.13 . . . . 0.0 113.977 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.34 56.07 8.44 Favored Glycine 0 N--CA 1.495 2.575 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.559 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 76' ' ' CYS . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 59' ' ' ARG . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -153.73 155.99 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.0 164.29 36.76 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.537 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.62 166.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.41 -38.15 0.14 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.25 97.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.045 -1.078 . . . . 0.0 111.458 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -80.01 -178.93 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.196 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 98.0 m -100.1 174.22 6.26 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 11.1 pt-20 -157.4 46.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.234 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NE ' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -146.35 -122.07 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.424 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.435 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 8.0 p-10 -97.86 3.22 49.83 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 -78.98 157.97 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HA ' HG22 ' A' ' 26' ' ' VAL . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 23' ' ' TYR . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.552 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t -88.33 36.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 51.99 19.09 0.92 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.974 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.63 -36.29 69.29 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.448 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 44' ' ' CYS . 3.4 t -139.9 -122.63 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' H ' HG23 ' A' ' 43' ' ' THR . 31.9 t 64.88 30.38 12.08 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.202 1.001 . . . . 0.0 113.661 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -79.89 89.53 5.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 47' ' ' VAL . 34.9 t 53.5 37.85 26.69 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.472 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 46' ' ' SER . 14.0 p 55.65 -21.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 C-N-CA 128.593 2.757 . . . . 0.0 115.072 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' SER . 59.9 p -89.25 42.07 1.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 55' ' ' SER . 28.3 p 43.4 -174.07 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 52' ' ' GLY . 86.4 tttt -37.14 133.32 0.66 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.6 t -89.7 31.88 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.734 1.254 . . . . 0.0 108.751 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -126.94 -38.26 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.463 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HG3' HG22 ' A' ' 60' ' ' VAL . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 59' ' ' ARG . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 48' ' ' THR . 61.8 t-20 -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 82' ' ' GLU . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -143.62 125.48 15.18 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 178.07 9.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.005 0.816 . . . . 0.0 110.252 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.89 -35.3 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.859 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.42 23.67 77.34 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.313 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.6 148.66 51.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.985 0.462 . . . . 0.0 111.354 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -79.74 179.57 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.621 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . 68.0 m -94.99 179.69 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.639 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -158.35 49.93 0.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.4 -122.15 0.1 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.437 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 8.9 p-10 -98.82 -0.91 41.57 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 -79.56 154.51 28.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 26' ' ' VAL . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 23' ' ' TYR . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.482 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t -89.85 34.16 0.85 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.6 tt0 44.54 29.81 0.44 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.3 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -58.09 -37.86 75.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.553 1.168 . . . . 0.0 108.334 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 44' ' ' CYS . 1.6 t -126.23 -100.78 0.37 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.6 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 43' ' ' THR . 9.8 t 63.31 48.31 3.66 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.974 1.309 . . . . 0.0 108.714 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.55 -22.88 9.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.792 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -85.93 -100.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.52 147.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 123.091 0.244 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t 34.42 49.11 0.32 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 124.836 1.335 . . . . 0.0 112.623 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 p -63.02 168.13 4.29 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.893 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HE3' ' SG ' ' A' ' 44' ' ' CYS . 18.4 ptpt -131.42 -154.98 0.66 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.074 -1.875 . . . . 0.0 110.379 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.8 t 63.74 41.91 6.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.5 1.125 . . . . 0.0 111.433 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.16 22.76 0.57 Allowed Glycine 0 N--CA 1.5 2.926 0 CA-C-N 113.344 -1.753 . . . . 0.0 117.14 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.638 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -140.6 44.59 1.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.418 0.627 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.16 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.23 150.11 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.721 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.33 41.2 99.45 Favored Glycine 0 N--CA 1.498 2.782 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.342 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.72 129.86 40.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -87.12 -175.82 5.47 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.8 m -142.6 168.35 19.93 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.851 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.6 pt-20 -152.54 44.72 0.7 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.814 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.69 -121.68 0.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -92.8 5.59 50.64 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 -98.63 146.73 25.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.568 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t -87.67 31.09 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 51.48 10.14 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.623 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -49.37 -34.93 17.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 t -151.0 51.04 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.612 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.5 t -80.94 -6.05 58.23 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.6 mm? -79.11 -36.2 41.03 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 123.86 0.725 . . . . 0.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -68.2 -179.31 1.23 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.146 0.904 . . . . 0.0 111.678 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 p 36.17 47.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 124.925 1.391 . . . . 0.0 112.291 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.5 m 53.7 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 53' ' ' ASP . 30.1 p -46.34 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.356 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 4.4 ttmp? -151.0 63.5 0.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.212 -1.813 . . . . 0.0 106.842 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.3 t -152.48 50.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.891 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.77 22.4 Favored Glycine 0 N--CA 1.502 3.06 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.775 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.522 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 59' ' ' ARG . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 49.06 42.66 21.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.42 0.718 . . . . 0.0 111.989 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.23 91.84 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.417 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 5' ' ' GLY . 61.7 t 61.04 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 4' ' ' VAL . . . -161.58 -73.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -117.77 88.84 2.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -97.96 -175.68 3.22 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.111 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 94.9 m -108.47 176.0 5.27 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.455 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.4 pt-20 -147.35 42.82 1.1 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.33 -117.78 0.11 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.73 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -107.9 15.03 24.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 -86.3 161.93 18.5 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.538 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 23' ' ' TYR . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t -90.06 40.3 1.0 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 36.44 31.81 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -61.06 -37.14 81.59 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -124.96 -146.51 0.35 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.6 t 45.65 20.27 0.06 Allowed 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 122.065 0.935 . . . . 0.0 111.752 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.4 tp -163.51 -53.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.088 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -87.18 62.03 7.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.536 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -170.46 174.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 112.701 -2.045 . . . . 0.0 105.572 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -70.01 74.74 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.492 0.663 . . . . 0.0 110.02 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.8 m -154.52 168.62 26.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.919 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 51' ' ' SER . 3.4 tmmm? -141.14 152.17 44.49 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.461 ' N ' ' HD2' ' A' ' 50' ' ' LYS . 80.2 p -82.54 25.98 0.6 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.27 -8.79 0.33 Allowed Glycine 0 N--CA 1.502 3.087 0 CA-C-N 113.679 -1.601 . . . . 0.0 113.55 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m 54.53 -151.0 0.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.35 0.676 . . . . 0.0 111.349 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.76 63.19 2.33 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.756 0.788 . . . . 0.0 111.814 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.73 -34.84 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.19 59.95 2.09 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 123.721 0.638 . . . . 0.0 113.432 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 72.71 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.53 0.681 . . . . 0.0 110.418 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -94.08 167.21 11.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.38 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 85.7 m -125.4 171.46 10.43 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.753 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.5 pt-20 -144.53 41.88 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.2 -117.86 0.12 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.844 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -112.35 11.52 20.04 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 -78.31 161.07 27.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.652 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' O ' HG22 ' A' ' 26' ' ' VAL . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.564 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t -90.28 30.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 43.05 36.28 0.9 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.344 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.62 -45.52 92.46 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 44' ' ' CYS . 3.0 t -114.14 -119.33 0.31 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 112.499 -2.137 . . . . 0.0 106.561 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.404 ' H ' HG23 ' A' ' 43' ' ' THR . 12.2 t 64.56 43.72 4.29 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.884 1.274 . . . . 0.0 111.987 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -85.69 68.12 10.29 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' THR . 40.2 t 60.05 88.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.361 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 48' ' ' THR . 7.7 p 38.36 -60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.641 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 ' H ' HG13 ' A' ' 47' ' ' VAL . 34.6 p -76.8 49.56 0.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 111.554 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.5 p 37.46 -153.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.392 1.477 . . . . 0.0 113.207 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.52 139.26 20.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.4 t -88.25 31.85 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.158 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.95 -34.07 1.19 Allowed Glycine 0 N--CA 1.495 2.594 0 CA-C-N 112.615 -2.084 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 68' ' ' TRP . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.413 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 156.22 46.42 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.885 -0.658 . . . . 0.0 109.567 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.79 86.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.534 1.147 . . . . 0.0 111.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.69 -163.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.379 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.58 28.43 72.29 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.5 85.3 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.576 0.703 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -92.44 168.27 11.39 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.724 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 68.5 m -139.94 173.45 11.51 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.468 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.09 43.91 1.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -118.78 0.12 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.94 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.79 2.08 35.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 -79.38 154.9 28.67 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.479 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 23' ' ' TYR . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t -86.43 29.12 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 38.98 37.74 0.24 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.056 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.36 -46.42 90.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 45' ' ' LEU . 4.3 t -107.09 -127.81 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.169 -2.159 . . . . 0.0 105.169 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t 62.95 28.7 16.4 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.741 1.217 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -78.83 90.34 4.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.3 m 66.5 -76.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.389 1.68 . . . . 0.0 108.088 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -171.94 -28.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.2 p -81.96 34.7 0.41 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.455 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p 37.29 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 52' ' ' GLY . 28.9 mtpp -29.72 123.7 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.579 1.174 . . . . 0.0 112.668 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -82.62 27.44 0.52 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -124.92 -33.02 0.76 Allowed Glycine 0 N--CA 1.495 2.606 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.417 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' HB3' HD12 ' A' ' 64' ' ' ILE . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -70.1 158.81 35.05 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.947 0.44 . . . . 0.0 110.618 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.11 147.81 27.53 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.64 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 5' ' ' GLY . 9.7 p 32.95 -119.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.98 1.425 . . . . 0.0 113.376 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.455 ' H ' HG13 ' A' ' 4' ' ' VAL . . . 93.94 -23.76 29.61 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -133.08 78.24 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.392 0.615 . . . . 0.0 111.59 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -95.0 176.62 6.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.6 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 92.2 m -90.11 172.73 8.61 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.577 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.3 pt-20 -151.48 45.07 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -142.09 -117.97 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.076 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -108.36 10.79 27.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 -79.1 156.19 28.42 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t -87.65 40.21 0.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 50.8 21.95 1.04 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.34 -37.3 85.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.004 0.907 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -152.2 30.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.661 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -92.64 25.56 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.274 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.8 mm? -103.76 -32.39 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.149 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -100.93 -177.06 3.35 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.489 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 34.17 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p 33.43 48.5 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.706 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p -40.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.517 -2.129 . . . . 0.0 116.09 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 52.63 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.895 0.747 . . . . 0.0 111.295 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -146.59 34.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.016 0.912 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.49 2.64 69.13 Favored Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.949 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 63' ' ' CYS . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG3' HG22 ' A' ' 60' ' ' VAL . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.567 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 79' ' ' GLY . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -63.76 -36.82 85.13 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.028 0.487 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.33 53.22 12.24 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.449 1.093 . . . . 0.0 112.298 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -73.73 162.5 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.755 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.43 -9.37 61.21 Favored Glycine 0 N--CA 1.498 2.827 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.237 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 134.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -97.89 168.46 10.29 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.651 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.6 m -134.0 168.19 19.25 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.773 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.8 pt-20 -145.87 42.09 1.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.845 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.81 -119.59 0.15 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.314 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.1 p30 -99.53 16.71 22.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 -105.47 152.49 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.576 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t -89.35 28.91 1.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 46.38 28.8 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.88 -31.35 66.64 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 45' ' ' LEU . 3.1 t -129.67 -120.71 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 111.125 -2.761 . . . . 0.0 105.039 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' H ' HG23 ' A' ' 43' ' ' THR . 10.6 t 82.17 -22.85 0.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.575 1.95 . . . . 0.0 109.916 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -78.92 20.08 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.771 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.9 m -103.25 -61.57 1.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.85 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 124.314 1.009 . . . . 0.0 113.322 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.1 m 47.96 36.3 6.03 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.72 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.4 m -130.11 163.08 27.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.385 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.85 32.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p 43.11 37.07 1.07 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.548 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.48 15.57 0.32 Allowed Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.68 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 m -67.9 123.52 20.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.039 0.493 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.88 87.49 5.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.031 0.832 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.61 -169.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.707 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.11 36.45 91.92 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 53.27 89.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.904 1.002 . . . . 0.0 113.326 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -79.79 179.18 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.795 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.73 161.19 21.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.681 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.9 pt-20 -160.69 23.7 0.15 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.082 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.681 ' HD2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -145.66 -116.86 0.08 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.057 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -109.78 8.6 24.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 -78.97 159.06 27.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' HA ' HG22 ' A' ' 26' ' ' VAL . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.569 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 21' ' ' ILE . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t -93.98 36.8 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 60.28 -11.37 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -44.35 -33.43 1.63 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 121.05 1.75 . . . . 0.0 112.277 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.2 p -102.68 -121.21 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.062 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t 57.78 23.24 9.36 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.457 1.903 . . . . 0.0 110.394 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 49' ' ' CYS . 67.6 mt -79.53 -79.81 0.13 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.446 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m 37.6 -103.91 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 48' ' ' THR . 17.7 m -49.44 -104.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.169 0.987 . . . . 0.0 113.525 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 ' H ' HG23 ' A' ' 47' ' ' VAL . 4.9 t -84.57 62.25 7.18 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 55' ' ' SER . 24.5 p -55.15 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 53.11 23.28 2.94 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 123.646 1.689 . . . . 0.0 109.086 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.1 t 60.21 61.81 1.74 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 111.55 -2.568 . . . . 0.0 114.557 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.08 34.71 2.1 Favored Glycine 0 N--CA 1.503 3.154 0 CA-C-N 113.068 -1.878 . . . . 0.0 116.683 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.675 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.61 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.4 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -72.78 96.0 1.99 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.161 -0.52 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.04 56.05 7.27 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.529 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.08 150.41 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.304 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.83 -13.04 3.91 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.24 36.18 0.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.451 -0.874 . . . . 0.0 111.297 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -93.68 -167.99 1.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.721 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 63.9 m -145.69 173.91 11.66 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.27 45.32 0.97 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.5 -118.75 0.11 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.219 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -103.74 5.48 36.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 -82.76 156.82 23.51 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CD1' HG21 ' A' ' 43' ' ' THR . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 23' ' ' TYR . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t -96.52 34.67 1.6 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 29.66 57.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.399 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -85.42 -37.62 19.59 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.249 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 13' ' ' PHE . 5.6 t -122.5 -6.73 8.68 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.785 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 28.9 t -63.25 -5.47 3.4 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.313 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -83.38 31.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.778 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.9 m -142.89 -65.45 0.39 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.98 84.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 124.347 1.029 . . . . 0.0 110.361 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m 49.9 69.03 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 27.9 p -64.2 167.21 6.87 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.754 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -170.26 90.26 0.17 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.789 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -162.36 52.62 0.21 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.65 32.09 58.19 Favored Glycine 0 N--CA 1.498 2.798 0 CA-C-N 113.459 -1.7 . . . . 0.0 113.386 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.556 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 64' ' ' ILE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 m -72.6 94.82 1.76 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.129 0.546 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.92 2.84 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.14 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.6 173.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.76 37.44 34.18 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.29 109.1 5.1 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.376 0.608 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -103.45 -170.33 1.77 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.235 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 94.1 m -119.86 172.02 8.01 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.2 pt-20 -145.77 42.47 1.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -137.92 -118.18 0.15 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.229 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -103.99 11.27 35.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 -90.16 156.93 18.0 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.56 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t -86.17 38.97 0.79 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 42.45 24.31 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.21 -40.57 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 t -148.02 89.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.008 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -125.68 1.14 7.5 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.139 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.4 mm? -78.8 -19.42 52.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.862 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -65.9 158.01 29.11 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.92 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' H ' ' A' ' 48' ' ' THR . 11.2 p 37.67 -123.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 124.762 1.289 . . . . 0.0 111.644 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 47' ' ' VAL . 98.4 m -92.36 101.92 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.64 -172.75 1.96 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.176 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -168.02 76.1 0.13 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -149.94 40.23 0.8 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.911 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.86 5.27 3.95 Favored Glycine 0 N--CA 1.501 3.008 0 CA-C-N 114.407 -1.269 . . . . 0.0 115.779 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.523 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 82' ' ' GLU . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' HA2' ' A' ' 79' ' ' GLY . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.0 m -69.45 136.09 51.07 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.913 0.419 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.87 157.83 35.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.976 0.797 . . . . 0.0 110.638 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.64 179.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.926 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.46 -0.66 47.82 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.85 70.96 9.95 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.668 -0.766 . . . . 0.0 110.843 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.53 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -78.59 176.2 9.67 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.585 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . 77.6 m -121.52 175.86 5.98 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.068 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.0 pt-20 -148.06 43.44 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.53 -118.01 0.13 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.626 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.47 1.38 41.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -79.47 157.88 27.39 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t -88.63 29.46 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 68.37 -0.25 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.46 -30.78 1.49 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -151.63 32.42 0.56 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.56 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.9 t -89.34 22.18 3.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.049 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -105.2 -31.16 9.25 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.612 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 p -88.73 -112.31 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.607 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.84 139.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.227 0.329 . . . . 0.0 111.687 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t 35.1 46.95 0.25 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 125.033 1.458 . . . . 0.0 113.095 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.4 p -58.4 165.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.982 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -164.13 88.83 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.998 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -171.66 49.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.91 35.86 64.87 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 60' ' ' VAL . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.427 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.816 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CZ ' ' H ' ' A' ' 63' ' ' CYS . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.477 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 22' ' ' SER . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.558 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 CA-C-O 119.478 -0.623 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.618 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.563 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 61' ' ' ASN . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 60' ' ' VAL . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.505 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 120.216 -0.214 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 76' ' ' CYS . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 54' ' ' PHE . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.518 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.587 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.702 0 CA-C-O 119.726 -0.486 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.69 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.552 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 23' ' ' TYR . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.834 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HE ' ' HG3' ' A' ' 66' ' ' GLN . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HA ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.506 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.866 0 CA-C-O 119.958 -0.357 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.627 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.414 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.682 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.554 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.575 0 N-CA-C 113.559 0.183 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 76' ' ' CYS . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 59' ' ' ARG . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HA ' HG22 ' A' ' 26' ' ' VAL . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 23' ' ' TYR . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.552 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HG3' HG22 ' A' ' 60' ' ' VAL . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 59' ' ' ARG . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 82' ' ' GLU . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 26' ' ' VAL . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 23' ' ' TYR . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.482 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.638 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.568 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.06 0 N-CA-C 113.775 0.27 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.522 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 59' ' ' ARG . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.502 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.538 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 23' ' ' TYR . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t . . . . . 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.087 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.437 ' H ' ' ND2' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.177 0.989 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' O ' HG22 ' A' ' 26' ' ' VAL . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.564 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 68' ' ' TRP . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.413 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.479 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 23' ' ' TYR . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.417 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' HB3' HD12 ' A' ' 64' ' ' ILE . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 tm0? -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.552 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.841 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 63' ' ' CYS . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG3' HG22 ' A' ' 60' ' ' VAL . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.567 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 79' ' ' GLY . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.576 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.83 0 CA-C-O 120.023 -0.321 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' HA ' HG22 ' A' ' 26' ' ' VAL . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.569 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 21' ' ' ILE . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.154 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.675 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.4 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 23' ' ' TYR . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.556 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 64' ' ' ILE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.56 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.523 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 82' ' ' GLU . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' HA2' ' A' ' 79' ' ' GLY . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 60' ' ' VAL . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.427 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.9 m -143.9 -48.98 0.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.171 -0.515 . . . . 0.0 109.958 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.88 63.69 2.08 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.457 1.098 . . . . 0.0 111.667 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 5' ' ' GLY . 11.2 p 44.91 163.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.456 ' N ' HG22 ' A' ' 4' ' ' VAL . . . 155.72 -19.88 0.51 Allowed Glycine 0 N--CA 1.496 2.689 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.291 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.51 66.37 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.149 -1.025 . . . . 0.0 111.482 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -78.96 -176.74 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.458 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.17 165.32 12.67 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.9 pt-20 -148.75 42.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.891 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HD2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -136.74 -118.35 0.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.775 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.3 OUTLIER -102.25 6.18 40.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.6 mt-10 -80.59 160.61 25.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.929 0.871 . . . . 0.0 112.4 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -92.87 112.7 24.75 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.064 -1.88 . . . . 0.0 112.038 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.54 136.5 34.84 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.1 t -74.91 176.5 7.07 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.493 1.139 . . . . 0.0 112.377 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 20.4 tt0 -74.32 -32.37 62.81 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -75.32 -18.53 59.99 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.292 -2.231 . . . . 0.0 107.04 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.07 -9.61 65.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.5 ttmp? -68.46 120.53 14.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 30.8 t -83.62 136.33 34.27 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.436 1.112 . . . . 0.0 113.542 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.92 150.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.4 m -82.46 164.75 20.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.835 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.3 m-85 -59.14 -34.08 71.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -51.06 -25.43 4.93 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.2 m0 -82.93 -40.15 20.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.968 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.7 m -69.39 148.05 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.995 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t 48.41 36.51 7.29 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.915 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -88.55 -12.72 41.97 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.454 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.77 -21.29 7.55 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 124.425 1.078 . . . . 0.0 112.125 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.2 t -129.33 171.08 12.85 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.09 0.948 . . . . 0.0 112.227 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.82 105.08 17.19 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.951 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 6.0 mp0 -79.8 -24.95 41.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.3 t -78.51 -11.16 59.94 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 124.204 0.94 . . . . 0.0 110.617 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 60.42 36.05 20.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -130.46 -55.51 1.09 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.131 -2.304 . . . . 0.0 104.95 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.58 -3.47 17.74 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -50.74 -60.49 3.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.764 0.92 . . . . 0.0 111.194 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.11 -9.24 15.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.747 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.32 4.21 11.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.544 1.153 . . . . 0.0 111.277 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.0 t -87.97 38.04 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.74 0.781 . . . . 0.0 111.939 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 52.44 18.49 0.95 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.96 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -56.03 -37.48 69.27 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.774 0.797 . . . . 0.0 111.557 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.5 t -155.34 46.26 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.633 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.4 t -95.32 17.37 14.55 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.47 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.8 mp -94.37 -23.27 17.86 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.226 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -101.17 -166.66 1.33 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.7 p 34.12 58.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.465 1.126 . . . . 0.0 111.519 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m 56.42 83.82 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.724 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.0 p -61.64 175.05 0.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.909 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -161.89 90.41 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.525 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -167.56 45.13 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.12 33.5 61.1 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -79.05 160.48 27.1 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.689 -0.756 . . . . 0.0 111.115 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.0 t80 -94.48 67.23 3.39 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.964 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.0 t -72.61 103.08 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 88.6 m -59.89 -29.41 68.32 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.439 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.46 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.484 1.869 0 N-CA-C 117.871 1.908 . . . . 0.0 117.871 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.35 -83.51 0.02 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 124.674 0.867 . . . . 0.0 114.091 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 80' ' ' SER . 29.7 ptt-85 -49.76 -48.23 50.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.756 0.915 . . . . 0.0 110.315 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.91 132.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -91.16 68.27 6.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CZ ' ' H ' ' A' ' 63' ' ' CYS . 3.4 tpm_? -132.17 127.51 36.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.558 -1.655 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' H ' ' CZ ' ' A' ' 62' ' ' ARG . 87.0 m -79.57 113.26 17.58 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 mm -99.41 139.0 20.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 112.772 -2.013 . . . . 0.0 106.88 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.62 133.58 57.48 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 N-CA-C 107.787 -1.659 . . . . 0.0 107.787 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -51.57 -45.97 63.29 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -59.69 -11.21 4.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.751 -1.18 . . . . 0.0 112.887 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.3 m0 -79.18 9.6 4.38 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 6.3 ppt_? -78.2 147.32 34.5 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.7 31.17 0.61 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 123.096 1.427 . . . . 0.0 109.832 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.97 -7.87 59.64 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 112.471 -2.149 . . . . 0.0 115.755 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.46 -36.41 1.8 Allowed Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.192 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -79.3 103.68 9.39 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 76.9 t -64.56 133.94 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 124.523 1.139 . . . . 0.0 111.049 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -125.62 -40.48 2.07 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.123 -1.853 . . . . 0.0 107.242 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.2 m -97.03 149.79 21.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.561 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -68.3 -13.09 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.084 0.865 . . . . 0.0 109.223 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 56.31 47.64 80.96 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.742 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.477 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 60.6 m -62.38 7.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.6 p-10 -116.67 13.68 15.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' CD ' ' HA ' ' A' ' 74' ' ' VAL . 1.2 pm0 -158.9 -51.88 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -74.34 -36.0 63.63 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -72.22 -0.51 45.54 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 111.521 -2.581 . . . . 0.0 114.923 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 122.415 1.102 . . . . 0.0 113.031 -179.644 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -140.85 -48.22 0.42 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.54 31.55 0.67 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -69.42 158.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.133 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.7 51.64 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.73 140.67 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.048 . . . . 0.0 113.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -98.08 -158.8 0.69 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.536 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 58.9 m -144.21 175.06 10.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.406 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.63 43.94 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -119.92 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.16 7.61 46.02 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.0 mt-10 -94.59 152.59 18.4 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.068 0.937 . . . . 0.0 110.654 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 43' ' ' THR . 81.4 t80 -90.8 132.15 36.03 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.722 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.84 136.21 33.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.059 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -83.92 178.2 7.99 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.277 1.037 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 13.8 tt0 -76.66 -31.17 57.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.26 -18.4 60.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.45 -2.159 . . . . 0.0 106.815 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.64 -10.03 68.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.87 134.68 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.202 0.59 . . . . 0.0 109.537 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 30.0 t -95.64 118.84 33.07 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.865 0.841 . . . . 0.0 112.763 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.99 152.04 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 57.1 m -87.16 171.04 10.97 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.258 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 26' ' ' VAL . 15.9 m-85 -59.86 -38.99 83.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 22' ' ' SER . 25.0 pttm -58.01 -13.06 3.95 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.496 -1.282 . . . . 0.0 109.135 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.558 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.7 m95 -89.99 -35.64 15.41 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.231 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' TYR . 24.3 m -72.39 139.17 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 t 45.0 37.25 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.417 -2.629 . . . . 0.0 111.827 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.69 -25.96 41.07 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.282 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.54 -9.36 1.88 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 124.012 0.82 . . . . 0.0 111.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -152.56 171.67 17.76 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.5 0.667 . . . . 0.0 110.544 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.82 105.21 17.13 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.248 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -80.41 -26.31 38.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.443 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.09 -8.22 58.79 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.867 0.729 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 62.1 32.45 17.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -129.14 -56.56 1.17 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 122.03 -7.55 10.02 Favored Glycine 0 C--O 1.211 -1.283 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 m -45.73 -61.78 1.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 124.895 0.997 . . . . 0.0 112.494 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.37 -21.52 65.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.161 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -103.29 3.11 35.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.757 1.286 . . . . 0.0 112.654 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.5 t -92.25 32.74 1.14 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.886 0.85 . . . . 0.0 109.853 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 43.88 31.83 0.54 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.533 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -60.25 -37.02 79.09 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 13' ' ' PHE . 5.4 t -145.48 40.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.57 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 46' ' ' SER . 18.6 t -76.56 5.42 7.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.369 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.509 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.1 mm? -78.26 29.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.38 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 44' ' ' CYS . 56.7 m -135.5 -102.14 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.27 139.67 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 ' H ' ' ND2' ' A' ' 61' ' ' ASN . 8.7 t 33.49 56.56 0.53 Allowed 'General case' 0 N--CA 1.505 2.315 0 O-C-N 124.719 1.262 . . . . 0.0 113.018 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.8 p -69.03 170.33 10.11 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.092 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -166.25 77.57 0.23 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.873 -1.967 . . . . 0.0 106.611 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 m -153.49 41.9 0.55 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.645 0.736 . . . . 0.0 111.649 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.93 2.57 39.06 Favored Glycine 0 N--CA 1.497 2.758 0 CA-C-N 114.757 -1.11 . . . . 0.0 114.504 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.92 171.56 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 117.474 0.637 . . . . 0.0 111.34 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 50.6 t80 -82.72 162.47 21.77 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.629 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.4 m -146.42 122.16 10.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.6 -59.73 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -158.23 30.57 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.94 -31.45 43.52 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.962 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -60.37 -44.48 95.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.52 126.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 48' ' ' THR . 6.0 t30 -91.32 61.96 4.56 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 5.8 tpm_? -100.68 111.13 23.31 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.697 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.618 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 88.1 m -79.2 123.06 27.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 31.1 mm -106.53 146.6 33.36 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.95 138.92 76.46 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -47.43 -53.41 14.12 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -56.12 -9.73 0.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 64' ' ' ILE . 15.9 m0 -78.51 7.68 6.32 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -77.36 148.86 35.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 t 38.32 39.33 0.28 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.918 1.342 . . . . 0.0 109.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.97 4.12 46.13 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.3 -22.03 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.247 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -103.02 104.3 14.47 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 117.458 0.629 . . . . 0.0 112.642 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.56 129.44 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 124.177 0.923 . . . . 0.0 111.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -119.46 -39.16 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.317 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.6 m -85.49 154.86 21.5 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.406 -1.724 . . . . 0.0 112.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.22 -56.31 23.15 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -73.83 -5.65 42.23 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.417 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 48.49 38.98 21.7 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 124.348 1.03 . . . . 0.0 111.76 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 p -70.15 19.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.7 p-10 -124.36 0.76 8.35 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.62 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -131.72 -62.2 0.87 Allowed 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -71.95 -37.47 69.96 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.26 41.61 3.01 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.721 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.329 1.062 . . . . 0.0 112.491 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.0 t 47.39 53.07 11.45 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.617 0.722 . . . . 0.0 110.239 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.89 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -46.63 154.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.663 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.05 10.6 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.22 89.17 2.53 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.279 -0.961 . . . . 0.0 111.224 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -81.11 -167.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.94 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 77.1 m -122.37 167.23 13.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.674 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -149.26 43.73 0.95 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.263 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -138.01 -118.84 0.14 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.655 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.474 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.6 p30 -98.85 1.26 45.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -82.45 157.79 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.81 0.814 . . . . 0.0 111.285 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -89.86 117.8 28.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.432 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -86.27 132.27 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -76.02 176.34 8.03 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.438 1.113 . . . . 0.0 111.586 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.54 -32.55 60.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 100.552 -3.87 . . . . 0.0 100.552 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.29 -19.68 60.99 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.45 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.0 -9.94 65.77 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -69.87 128.85 37.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.6 t -88.02 136.14 33.1 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -144.96 152.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -81.8 162.71 22.77 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.582 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.3 m-85 -58.83 -36.58 74.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -54.63 -18.1 4.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.914 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.563 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.0 m95 -84.86 -40.73 16.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.93 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 23' ' ' TYR . 12.8 m -69.92 148.46 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.009 0.909 . . . . 0.0 113.298 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.7 t 51.68 38.48 22.9 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.327 -2.215 . . . . 0.0 114.404 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -96.48 14.75 23.53 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.566 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.72 -20.93 41.85 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.479 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -122.4 168.77 11.68 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.071 0.938 . . . . 0.0 112.026 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.31 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.3 mp0 -82.17 -26.53 33.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -77.7 -7.29 56.27 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.836 0.71 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 57.59 34.6 24.75 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.2 -54.52 1.11 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 111.968 -2.378 . . . . 0.0 104.751 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.98 -2.8 22.77 Favored Glycine 0 C--O 1.209 -1.442 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 t -50.64 -58.26 6.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.829 0.958 . . . . 0.0 111.289 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.7 p-10 -60.48 -13.96 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -120.89 3.1 10.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.618 1.199 . . . . 0.0 112.23 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.9 t -89.23 41.51 1.04 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.22 0.534 . . . . 0.0 112.175 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 46.71 27.43 0.67 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.15 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.47 -32.75 70.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 t -152.73 22.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 112.495 -2.139 . . . . 0.0 110.754 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 t -84.58 16.92 2.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.506 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.42 14.27 14.61 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.685 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.4 p -126.87 -86.32 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.828 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.69 112.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m 49.35 55.51 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.147 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.02 165.74 3.15 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.461 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -168.38 73.41 0.1 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.452 -1.703 . . . . 0.0 108.155 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -150.8 44.4 0.83 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 56.92 31.31 61.12 Favored Glycine 0 N--CA 1.498 2.807 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.8 154.76 26.99 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.859 0.838 . . . . 0.0 111.88 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.696 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 12.4 t80 -81.53 77.41 8.39 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.411 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.1 m -76.07 114.61 14.91 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 60.9 m -48.31 -41.24 27.63 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 124.286 0.991 . . . . 0.0 109.727 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.51 179.35 1.07 Allowed Glycine 0 N--CA 1.488 2.113 0 CA-C-N 113.686 -1.597 . . . . 0.0 115.724 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.32 -98.12 0.16 Allowed Glycine 0 N--CA 1.493 2.5 0 CA-C-N 113.086 -1.557 . . . . 0.0 112.16 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.85 -22.65 65.69 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.189 -1.006 . . . . 0.0 113.325 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 61' ' ' ASN . 11.2 p -158.14 158.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.022 0.915 . . . . 0.0 110.398 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 60' ' ' VAL . 12.2 t30 -109.83 64.4 0.61 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 112.403 -2.18 . . . . 0.0 107.488 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 2.4 tpm_? -107.23 107.49 18.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 83.6 m -79.41 117.66 20.58 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.0 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.2 mm -107.12 132.59 20.81 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.09 109.95 2.82 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -25.81 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -64.63 -3.35 3.09 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 117.369 -1.732 . . . . 0.0 111.401 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 25.2 m0 -85.33 7.33 22.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -79.59 154.14 28.95 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.771 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 t 44.87 36.3 1.83 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.021 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 13.2 t70 -90.54 1.37 56.78 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.86 -26.81 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.252 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -100.09 104.33 15.89 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.51 129.81 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 124.187 0.929 . . . . 0.0 112.538 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -116.63 -41.38 3.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.696 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 34.8 m -86.27 144.28 27.49 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.526 -1.67 . . . . 0.0 110.89 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -57.01 -46.31 82.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.97 -20.16 61.77 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.305 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.7 38.99 74.63 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.076 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -77.98 31.9 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.772 1.272 . . . . 0.0 111.945 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 21.3 p-10 -134.75 1.64 3.08 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.288 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -131.52 -60.21 0.94 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -75.45 -41.34 55.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.37 62.87 4.03 Favored Glycine 0 N--CA 1.484 1.873 0 CA-C-N 112.497 -2.138 . . . . 0.0 108.45 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 122.338 1.066 . . . . 0.0 113.149 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -170.74 0.83 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.099 0.529 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.77 46.77 26.09 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.562 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.61 120.85 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.4 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.7 -10.86 58.61 Favored Glycine 0 N--CA 1.498 2.813 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.684 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -74.39 -164.97 0.29 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.056 0.455 . . . . 0.0 111.843 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -121.53 177.21 5.31 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.738 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.4 m -79.62 171.9 14.51 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.123 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.1 pt-20 -147.82 43.56 1.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.04 -117.14 0.14 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.952 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -104.83 9.18 34.92 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.2 mt-10 -85.34 157.67 20.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.284 1.04 . . . . 0.0 111.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 43' ' ' THR . 75.2 t80 -93.33 120.32 33.49 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.533 -2.121 . . . . 0.0 113.564 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -82.59 131.33 35.21 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 43.9 t -73.3 176.37 6.02 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.29 1.043 . . . . 0.0 111.387 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -74.59 -33.12 62.58 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.01 -18.38 60.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.09 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.61 -12.82 62.92 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.96 122.78 17.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.664 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 19.2 t -83.58 126.85 33.24 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.352 1.072 . . . . 0.0 113.483 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.67 151.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -83.08 174.85 10.47 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.7 m-85 -60.29 -32.95 71.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.421 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 11.6 mptt -62.0 -21.25 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.505 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.7 m95 -88.18 -20.63 25.32 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.374 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 23' ' ' TYR . 33.7 m -91.38 141.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t 40.53 41.54 1.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 112.309 -2.223 . . . . 0.0 112.1 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -85.74 -22.46 27.75 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.813 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 -16.07 1.89 Allowed Glycine 0 N--CA 1.487 2.039 0 O-C-N 123.902 0.751 . . . . 0.0 112.438 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -149.24 175.23 11.58 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.16 0.505 . . . . 0.0 110.08 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.97 108.89 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.93 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -86.37 -24.56 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.521 0.513 . . . . 0.0 111.933 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.1 t -79.15 -8.32 58.9 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 123.812 0.695 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 60.79 34.84 19.68 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.5 -53.61 0.95 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.3 -5.84 26.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 106.921 -2.472 . . . . 0.0 106.921 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.2 t -45.87 -58.91 3.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.996 1.057 . . . . 0.0 111.479 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.4 p-10 -60.43 -27.77 67.76 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.101 -2.318 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -98.92 0.64 44.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 125.187 1.554 . . . . 0.0 112.863 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.9 t -91.18 35.38 0.92 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.737 0.779 . . . . 0.0 111.489 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 44.96 20.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -57.43 -34.85 69.37 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 45' ' ' LEU . 8.2 t -136.35 28.09 3.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.642 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.7 t -86.49 23.34 1.64 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -100.46 113.33 26.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.4 p 56.5 -166.88 0.12 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 126.446 2.341 . . . . 0.0 110.417 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p 38.38 78.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.472 1.13 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m 59.15 55.99 4.11 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.643 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.8 p -82.45 -83.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.985 -1.461 . . . . 0.0 113.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 51.48 89.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.112 0.882 . . . . 0.0 110.943 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -129.6 30.47 4.91 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.134 0.968 . . . . 0.0 110.425 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.48 -7.18 5.15 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.96 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -79.6 -163.5 0.53 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 52.4 t80 -74.69 168.21 20.28 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 62.9 m -152.7 119.79 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.35 -44.52 82.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.173 -1.411 . . . . 0.0 107.809 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.16 165.23 0.12 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.159 -1.382 . . . . 0.0 114.867 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.05 -93.27 0.15 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 76' ' ' CYS . 27.3 ptt-85 -49.32 -47.35 47.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.769 0.923 . . . . 0.0 111.013 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.2 134.65 20.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -91.04 60.41 4.31 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.456 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -121.21 126.44 49.64 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.86 132.94 36.22 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.8 mm -108.02 130.91 22.16 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.48 105.81 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -23.91 -36.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 119.485 3.143 . . . . 0.0 119.485 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -68.66 0.18 4.5 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.756 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 20.2 m0 -90.91 3.96 53.17 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.807 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 54' ' ' PHE . 88.4 mtt180 -83.24 149.65 26.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.2 t 42.22 38.02 1.04 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 112.553 -2.112 . . . . 0.0 107.483 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.11 1.54 57.01 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.67 -27.83 0.74 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 120.61 -0.805 . . . . 0.0 114.103 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.32 101.01 12.58 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 117.697 0.748 . . . . 0.0 112.364 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.35 133.66 26.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.901 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.29 -40.37 2.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.267 -1.788 . . . . 0.0 107.151 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.518 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 81.8 m -83.94 151.82 24.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.446 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -52.15 -58.86 5.3 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.02 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -76.27 -14.02 60.14 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.458 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.8 53.49 30.7 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.081 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -73.29 20.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.3 p-10 -132.13 8.32 4.37 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.928 1.291 . . . . 0.0 109.742 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -134.15 -64.61 0.69 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -74.14 -38.62 63.7 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.15 35.9 1.95 Allowed Glycine 0 N--CA 1.485 1.918 0 CA-C-N 112.077 -2.329 . . . . 0.0 112.218 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 122.328 1.061 . . . . 0.0 112.573 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -72.03 89.95 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.204 0.591 . . . . 0.0 110.134 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.119 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.43 -175.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.16 43.5 5.3 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.7 122.8 24.53 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -96.42 179.35 5.05 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.282 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.7 m -97.22 159.54 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 12.3 pt-20 -160.62 22.78 0.15 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.445 1.116 . . . . 0.0 113.011 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.0 -114.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.323 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -114.35 20.21 15.66 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.669 0.388 . . . . 0.0 111.921 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 48.3 mt-10 -95.61 162.87 13.44 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -97.31 117.47 31.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.958 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.94 138.03 35.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.0 t -77.72 175.23 10.13 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.265 1.031 . . . . 0.0 111.766 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.0 tp-100 -74.95 -30.4 61.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.107 -3.294 . . . . 0.0 102.107 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 24.0 t70 -75.13 -20.32 59.47 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 112.211 -2.268 . . . . 0.0 106.581 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.66 -11.37 62.87 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.331 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -68.36 123.87 21.95 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 43.7 t -88.07 128.18 35.41 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.042 -1.463 . . . . 0.0 112.694 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.54 150.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -80.25 165.79 22.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.712 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 26' ' ' VAL . 21.8 m-85 -58.89 -35.87 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.464 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -53.13 -24.18 9.89 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.573 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.587 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.4 m95 -82.57 -34.37 27.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 23' ' ' TYR . 22.0 m -72.86 144.88 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t 45.64 41.06 6.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.9 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -94.27 24.93 4.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.5 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.69 -2.16 64.63 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.351 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.0 t -140.75 164.23 30.77 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.42 1.105 . . . . 0.0 111.543 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.35 106.98 17.84 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.419 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -82.19 -29.27 31.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.102 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.2 t -78.86 -7.67 58.12 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 58.31 32.43 22.06 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -126.99 -53.88 1.4 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 111.819 -2.446 . . . . 0.0 104.486 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.89 -2.82 25.8 Favored Glycine 0 C--O 1.209 -1.431 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.9 t -50.17 -59.4 3.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.759 0.917 . . . . 0.0 110.006 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.24 -19.46 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -105.6 2.6 28.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.805 1.316 . . . . 0.0 112.853 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 47.5 t -90.13 24.87 2.34 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.495 1.141 . . . . 0.0 113.244 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 63.72 4.18 1.79 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.18 -30.94 1.29 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 120.579 1.536 . . . . 0.0 114.848 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 t -149.55 49.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.305 1.003 . . . . 0.0 112.539 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 t -81.46 -3.86 54.19 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.307 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.3 mm? -82.37 -7.04 59.63 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.223 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.5 m -100.3 169.56 9.04 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.634 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p 34.13 97.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 124.972 1.42 . . . . 0.0 114.085 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 t 41.81 60.76 2.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 123.178 1.466 . . . . 0.0 111.009 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.6 p -49.81 168.52 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 112.455 -2.157 . . . . 0.0 114.381 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -147.39 82.97 1.54 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.252 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.2 p -164.37 37.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.87 23.91 57.05 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.781 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.29 156.28 26.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.167 0.984 . . . . 0.0 111.547 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.69 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 t80 -82.53 83.0 7.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 112.781 -2.008 . . . . 0.0 111.997 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -71.79 121.98 19.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 71.1 m -54.66 -49.99 69.28 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.704 -0.799 . . . . 0.0 112.366 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.69 -39.68 1.32 Allowed Glycine 0 N--CA 1.488 2.158 0 O-C-N 124.173 0.921 . . . . 0.0 115.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.03 -88.18 0.05 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.56 -47.82 69.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.312 0.654 . . . . 0.0 110.591 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 61' ' ' ASN . 6.5 p -162.64 170.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 107.944 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.1 p-10 -85.37 38.51 0.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.433 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 4.4 tpm_? -67.37 114.46 6.08 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.442 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.552 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 94.7 m -77.46 113.79 15.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG13 ' SG ' ' A' ' 76' ' ' CYS . 42.0 mm -96.08 132.49 26.81 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 112.253 -2.249 . . . . 0.0 106.04 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.43 143.82 99.49 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.03 -31.35 65.05 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.417 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.75 -24.39 3.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.148 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 45.5 m0 -104.3 42.34 1.21 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.356 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -122.14 129.51 52.4 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 103.649 -2.722 . . . . 0.0 103.649 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.536 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 37.2 t 59.41 52.17 6.08 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 126.874 2.069 . . . . 0.0 107.206 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -110.66 7.45 22.3 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.67 -22.89 1.07 Allowed Glycine 0 CA--C 1.552 2.345 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.843 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -104.24 106.39 16.87 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -67.09 134.83 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.64 -41.28 2.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 69.8 m -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.204 -1.816 . . . . 0.0 115.51 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.1 -51.83 67.96 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.974 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -67.06 -10.28 48.19 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.533 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 54.84 26.91 42.17 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.213 0.946 . . . . 0.0 112.053 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 51.9 m -72.93 24.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.6 p-10 -130.06 3.75 4.83 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.171 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.3 mp0 -137.88 -57.4 0.67 Allowed 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -78.37 -41.52 33.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -79.01 32.28 1.99 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 112.893 -1.958 . . . . 0.0 114.288 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.367 1.08 . . . . 0.0 112.71 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -158.83 -57.43 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.81 152.54 24.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.966 0.791 . . . . 0.0 111.226 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.86 169.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.797 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.56 -52.64 1.41 Allowed Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.956 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.4 t70 59.33 5.0 0.54 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -89.0 -177.21 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.524 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 42.9 m -129.39 175.7 8.55 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.45 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.79 47.46 0.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.04 -120.22 0.11 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.53 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.0 p30 -104.11 3.51 33.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.7 mt-10 -81.63 156.58 25.06 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.585 1.183 . . . . 0.0 112.942 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -94.26 116.37 28.75 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.48 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.52 132.72 36.4 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.96 176.1 6.03 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.289 1.042 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -75.07 -32.34 61.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.18 -18.11 60.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.663 -2.062 . . . . 0.0 107.685 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -10.7 62.8 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.16 116.0 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.206 -0.997 . . . . 0.0 109.505 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 24.8 t -81.08 119.94 24.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.159 0.981 . . . . 0.0 113.321 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -128.87 154.78 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 36.9 t -86.52 174.76 8.73 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.2 m-85 -59.07 -31.72 69.13 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -64.22 -22.9 67.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HB2' HD13 ' A' ' 21' ' ' ILE . 10.3 m95 -84.99 -14.9 46.01 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.244 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 23' ' ' TYR . 30.6 m -99.96 145.41 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.6 t 42.17 39.28 1.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.054 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -93.16 15.3 15.65 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.392 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.64 -24.2 33.13 Favored Glycine 0 N--CA 1.485 1.951 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.454 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -131.97 169.91 15.66 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.377 0.608 . . . . 0.0 111.541 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 114.4 27.16 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.358 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.92 -21.59 19.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.681 0.613 . . . . 0.0 112.167 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 t -78.52 -18.16 55.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.674 0.609 . . . . 0.0 110.169 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.8 47.98 1.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.354 -3.573 . . . . 0.0 101.354 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -146.03 -52.33 0.25 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 110.81 -5.42 29.23 Favored Glycine 0 C--O 1.21 -1.39 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 t -45.91 -58.28 3.67 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.656 1.217 . . . . 0.0 111.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 4.5 p-10 -60.6 -28.42 68.49 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 111.76 -2.473 . . . . 0.0 110.979 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -99.74 2.62 44.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 125.199 1.562 . . . . 0.0 112.434 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.9 t -88.08 30.92 0.82 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.785 0.802 . . . . 0.0 112.659 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 63.2 tt0 47.25 18.89 0.1 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.219 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -54.03 -35.05 61.53 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.032 0.92 . . . . 0.0 110.541 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -124.82 -124.01 0.25 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 t 82.61 -4.58 1.36 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.025 2.13 . . . . 0.0 114.132 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.8 mm? -79.0 35.36 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.027 0.441 . . . . 0.0 111.898 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.0 m -144.18 -62.44 0.38 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.01 80.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.157 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m 50.8 81.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.593 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 p -65.56 -169.95 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.621 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -169.62 84.83 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 t -153.51 42.89 0.58 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.083 0.944 . . . . 0.0 110.478 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.05 4.72 23.04 Favored Glycine 0 N--CA 1.499 2.834 0 CA-C-N 114.39 -1.277 . . . . 0.0 115.121 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.49 164.27 24.06 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.5 0.667 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 24.8 t80 -77.76 78.78 4.26 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.0 p -76.54 112.44 13.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 96.8 m -75.29 -50.57 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.559 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.74 -164.47 1.75 Allowed Glycine 0 N--CA 1.492 2.405 0 O-C-N 124.101 0.876 . . . . 0.0 113.929 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.46 -96.93 0.06 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -58.43 -34.18 70.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.6 0.824 . . . . 0.0 109.953 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.25 -157.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -166.39 87.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -172.59 135.82 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.3 m -82.81 120.48 25.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.089 -2.323 . . . . 0.0 108.523 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.1 mm -103.09 128.72 27.04 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 113.283 -1.781 . . . . 0.0 106.836 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.85 108.34 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 20.1 tt0 -24.14 -36.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 119.392 3.108 . . . . 0.0 119.392 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.4 -2.21 8.07 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.867 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.85 -3.26 58.87 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HE ' ' HG3' ' A' ' 66' ' ' GLN . 95.2 mtt-85 -70.63 169.08 15.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.1 t 27.84 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.431 1.892 . . . . 0.0 111.437 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.44 -7.25 24.51 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.26 -45.97 2.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.11 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -78.68 100.68 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.273 1.035 . . . . 0.0 112.063 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.82 146.69 11.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.226 -1.806 . . . . 0.0 114.694 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -127.91 -41.41 1.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.162 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' HG13 ' A' ' 64' ' ' ILE . 52.9 m -87.94 150.42 23.48 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.166 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -40.99 -67.58 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.091 0.87 . . . . 0.0 111.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.75 -25.31 62.0 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 73.03 45.86 30.54 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -76.11 30.89 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.979 1.371 . . . . 0.0 113.971 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 14.9 p-10 -121.03 -32.62 3.9 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.77 -53.15 3.64 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.36 -35.92 78.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.52 22.94 1.29 Allowed Glycine 0 N--CA 1.48 1.596 0 CA-C-N 111.789 -2.459 . . . . 0.0 113.62 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 122.469 1.128 . . . . 0.0 112.446 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -65.37 148.62 51.4 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.98 0.459 . . . . 0.0 111.089 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.68 170.29 19.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.953 0.783 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 5' ' ' GLY . 7.3 p -157.99 165.56 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.596 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 4' ' ' VAL . . . 115.61 -35.02 4.5 Favored Glycine 0 N--CA 1.497 2.706 0 CA-C-N 113.099 -1.864 . . . . 0.0 110.604 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.6 73.41 10.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.534 1.159 . . . . 0.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -101.72 -179.04 3.9 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.111 -1.859 . . . . 0.0 111.442 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.37 169.92 17.37 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.01 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.0 pt-20 -155.5 47.19 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.43 -120.08 0.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.872 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.2 OUTLIER -97.41 4.25 50.69 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 33.6 mt-10 -88.75 153.89 20.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.254 1.026 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.13 117.17 30.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 112.386 -2.188 . . . . 0.0 111.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -80.88 140.55 35.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 42.6 t -86.42 176.52 7.82 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.783 1.278 . . . . 0.0 110.733 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.538 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -73.2 -33.81 65.59 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -70.66 -22.26 62.51 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 111.735 -2.484 . . . . 0.0 106.757 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.99 -12.13 62.29 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -64.69 124.83 22.93 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.409 -0.896 . . . . 0.0 109.599 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 29.2 t -88.4 118.13 27.82 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.436 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -129.23 149.89 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -79.7 167.73 20.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 123.893 0.746 . . . . 0.0 111.364 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HA ' HG22 ' A' ' 26' ' ' VAL . 31.4 m-85 -59.56 -33.69 71.73 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.147 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.61 -26.98 15.07 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.506 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.0 m95 -84.46 -32.74 23.87 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.002 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 23' ' ' TYR . 19.5 m -76.85 147.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.8 t 44.71 37.91 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.96 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -91.16 18.42 6.92 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.413 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.52 53.38 Favored Glycine 0 N--CA 1.485 1.905 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 t -130.08 167.74 17.85 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.041 0.924 . . . . 0.0 111.524 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.47 108.92 20.39 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.3 mp0 -86.72 -21.8 26.39 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.018 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 41.3 t -78.21 -19.64 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.951 0.782 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 74.95 33.38 0.75 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 125.537 1.773 . . . . 0.0 107.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.9 -52.72 0.8 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.581 -2.1 . . . . 0.0 106.697 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.17 -1.33 19.17 Favored Glycine 0 C--O 1.21 -1.404 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 35.4 t -49.43 -59.79 3.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.838 0.963 . . . . 0.0 109.917 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.55 -19.7 58.13 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.949 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -108.89 2.0 21.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.882 1.364 . . . . 0.0 113.477 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.7 t -89.99 42.83 1.11 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.624 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 48.8 mt-30 51.34 16.35 0.4 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -57.81 -36.5 72.3 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.456 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' LEU . 7.0 t -144.18 34.2 1.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.391 -1.732 . . . . 0.0 112.811 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 41' ' ' GLN . 40.8 m -78.78 16.44 0.87 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.803 . . . . 0.0 110.828 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.4 mm? -98.38 -27.86 13.9 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.6 p -110.23 -179.17 3.7 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.338 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 32.33 87.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 124.787 1.304 . . . . 0.0 113.551 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 ' H ' HD21 ' A' ' 61' ' ' ASN . 96.1 m 54.44 68.97 0.77 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -55.34 176.46 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.928 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -165.72 87.27 0.38 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.294 -1.321 . . . . 0.0 107.598 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 p -164.52 41.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.19 26.32 65.79 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.785 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -86.48 157.02 19.88 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.892 0.853 . . . . 0.0 111.376 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 29.1 t80 -82.32 80.21 8.57 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.403 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.4 m -72.51 121.87 20.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.7 m -52.42 -42.59 64.21 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.677 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.23 158.57 0.17 Allowed Glycine 0 N--CA 1.489 2.207 0 O-C-N 124.701 1.251 . . . . 0.0 112.294 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.07 -104.71 2.26 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -51.89 -43.12 63.19 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 59' ' ' ARG . 33.7 m -143.16 174.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.436 0.636 . . . . 0.0 112.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.408 HD21 ' H ' ' A' ' 48' ' ' THR . 8.6 t30 -113.89 42.36 2.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.1 tpm_? -82.88 104.37 13.05 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.762 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.627 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 71.2 m -78.22 114.44 17.11 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.786 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.1 mm -99.83 135.28 20.53 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-N 113.063 -1.88 . . . . 0.0 107.524 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 19.6 Cg_endo -63.5 142.11 83.33 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 106.907 -1.997 . . . . 0.0 106.907 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -54.86 -33.65 62.06 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.912 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -47.85 -25.32 1.26 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.882 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.441 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.0 m0 -102.1 42.83 1.11 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.551 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -117.99 136.7 53.35 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.6 t 51.58 48.94 21.93 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.656 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -106.56 7.23 30.67 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.414 ' CA ' ' HG3' ' A' ' 82' ' ' GLU . . . 73.48 -22.32 1.07 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.85 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 71' ' ' ASP . 17.8 tt0 -105.8 106.62 17.22 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.5 137.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.29 -41.16 2.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 60.6 m -92.82 146.81 23.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.248 -1.796 . . . . 0.0 115.282 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.77 -51.49 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.48 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.68 -11.84 48.51 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.13 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 53.71 25.52 29.34 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.564 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -74.27 30.75 0.08 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.252 1.025 . . . . 0.0 113.631 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.682 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.5 p-10 -131.68 1.08 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.7 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 72' ' ' GLY . 2.5 mp0 -137.4 -57.33 0.7 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.73 -42.06 58.99 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.98 60.64 4.12 Favored Glycine 0 N--CA 1.487 2.037 0 CA-C-N 112.677 -2.056 . . . . 0.0 110.698 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 122.185 0.993 . . . . 0.0 112.755 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -145.06 150.52 37.0 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.143 0.555 . . . . 0.0 109.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.89 70.31 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.373 1.045 . . . . 0.0 111.506 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.96 -34.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.44 44.45 0.71 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -76.12 17.56 0.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.498 -0.851 . . . . 0.0 113.256 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -79.21 175.31 10.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.272 0.558 . . . . 0.0 111.955 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.31 176.37 5.93 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.978 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.4 pt-20 -148.9 43.79 0.98 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.75 -118.29 0.12 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.897 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -102.83 4.84 38.24 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 42.8 mt-10 -79.33 158.17 27.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.122 0.963 . . . . 0.0 112.276 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -92.62 117.07 29.58 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -82.5 136.77 34.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.8 t -79.11 177.01 9.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.457 1.123 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 50.7 tt0 -74.79 -32.15 61.93 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 101.638 -3.467 . . . . 0.0 101.638 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.2 -17.67 59.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.19 -2.277 . . . . 0.0 107.165 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.59 62.67 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.56 123.35 18.58 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.974 -0.613 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 21.3 t -88.87 124.14 33.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -128.53 151.37 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -80.09 167.36 20.5 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.832 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.0 m-30 -59.63 -34.81 73.27 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -55.15 -22.04 15.6 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.088 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.554 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.1 m95 -84.8 -35.08 22.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.038 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 23' ' ' TYR . 18.1 m -76.16 148.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.605 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.1 t 51.11 37.66 18.71 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 112.649 -2.069 . . . . 0.0 114.996 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -97.25 23.37 7.52 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.596 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.17 18.28 70.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.963 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -153.65 165.89 34.51 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.043 0.925 . . . . 0.0 110.767 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.29 113.41 26.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.724 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 7.8 mp0 -92.22 -25.95 18.41 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.332 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.93 -10.98 59.85 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 124.167 0.917 . . . . 0.0 110.693 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.14 41.47 13.56 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -137.44 -55.55 0.69 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 115.14 -0.97 22.61 Favored Glycine 0 C--O 1.21 -1.358 0 N-CA-C 106.779 -2.529 . . . . 0.0 106.779 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 t -51.75 -58.44 6.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.768 0.922 . . . . 0.0 111.023 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.62 -8.65 15.06 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.458 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -120.89 4.8 10.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.578 1.174 . . . . 0.0 111.234 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 38.7 t -85.72 37.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.644 0.735 . . . . 0.0 111.574 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 34.46 56.88 0.68 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -96.92 -43.68 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 t -135.08 36.63 3.03 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.885 -1.961 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 49' ' ' CYS . 16.4 t -98.89 37.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.02 8.04 3.46 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 111.69 -2.505 . . . . 0.0 110.585 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.8 m -134.47 -159.05 0.93 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t 60.99 -78.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 124.283 0.989 . . . . 0.0 110.364 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.8 m -141.83 42.69 1.7 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 46.9 t -150.87 175.48 11.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.475 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 40.2 ttmt -150.76 120.49 7.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p 39.14 33.24 0.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.508 1.13 . . . . 0.0 113.977 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.34 56.07 8.44 Favored Glycine 0 N--CA 1.495 2.575 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.559 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 66.9 m-20 -77.79 -169.09 1.39 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 88.6 t80 -51.98 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.9 m -78.64 105.9 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 t -56.65 -45.05 81.86 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.299 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.33 -163.2 7.42 Favored Glycine 0 N--CA 1.477 1.43 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.848 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.28 -94.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 76' ' ' CYS . 8.6 ptp85 -56.47 -41.98 77.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.541 -0.83 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.0 m -133.2 -156.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.45 94.4 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -166.71 127.47 1.63 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.28 130.12 35.14 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 44.5 mm -112.04 128.89 24.85 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.7 Cg_endo -49.13 136.54 30.16 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -52.42 -28.82 21.48 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.031 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.98 -26.0 33.73 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.784 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.6 m0 -109.62 39.78 2.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.75 118.43 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 35.8 t 73.44 48.47 0.16 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.026 2.53 . . . . 0.0 107.777 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -113.37 4.67 16.45 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 112.863 -1.972 . . . . 0.0 111.915 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.73 2.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -79.14 102.78 8.65 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.522 0.677 . . . . 0.0 112.595 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 79' ' ' GLY . 69.1 t -53.74 132.14 16.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -117.22 -36.24 3.83 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.854 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 59' ' ' ARG . 99.2 m -77.83 169.48 18.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.74 -39.34 94.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.48 -55.53 3.69 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.593 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 120.88 45.6 0.37 Allowed Glycine 0 N--CA 1.492 2.432 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.432 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -76.05 28.76 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 13.6 p-10 -119.98 -35.98 3.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.03 -53.93 3.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.58 -39.58 62.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.3 38.2 2.88 Favored Glycine 0 N--CA 1.483 1.83 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.068 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 123.142 1.449 . . . . 0.0 110.351 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -153.73 155.99 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.0 164.29 36.76 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.537 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.62 166.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.41 -38.15 0.14 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.25 97.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.045 -1.078 . . . . 0.0 111.458 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -80.01 -178.93 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.196 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 98.0 m -100.1 174.22 6.26 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 11.1 pt-20 -157.4 46.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.234 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NE ' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -146.35 -122.07 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.424 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.7 p30 -97.86 3.22 49.83 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 44.0 mt-10 -78.98 157.97 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.415 1.102 . . . . 0.0 111.437 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -94.96 105.99 17.95 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.122 -2.308 . . . . 0.0 113.668 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -73.57 137.53 44.37 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 43.5 t -74.27 173.0 10.81 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.314 1.054 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.414 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 66.8 tt0 -75.87 -28.22 58.08 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 19.1 t70 -74.49 -22.2 59.18 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 112.171 -2.286 . . . . 0.0 106.256 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.09 -11.25 57.2 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.68 118.49 15.68 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 36.0 t -81.7 134.66 35.49 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.923 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.31 153.62 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 111.385 -2.643 . . . . 0.0 104.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -88.38 173.47 8.71 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.47 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HA ' HG22 ' A' ' 26' ' ' VAL . 43.4 m-85 -57.35 -41.4 80.0 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -57.31 -15.73 6.99 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.2 m95 -86.68 -37.08 18.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.142 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 23' ' ' TYR . 17.1 m -79.03 153.25 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.443 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.7 t 51.44 36.84 17.67 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.757 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 p30 -103.07 25.77 9.02 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.97 14.96 57.48 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.742 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.9 t -148.95 166.23 29.21 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.043 0.925 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.87 115.48 30.3 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.916 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.1 mp0 -99.84 -22.02 15.49 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 36.9 t -76.75 -14.72 59.91 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.934 0.771 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 72.02 31.88 1.92 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 125.247 1.592 . . . . 0.0 108.619 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -136.64 -49.15 0.64 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.212 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.28 2.39 23.21 Favored Glycine 0 C--O 1.209 -1.467 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.552 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 40.5 t -51.94 -57.31 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.839 0.964 . . . . 0.0 111.238 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.55 -5.58 5.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.956 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -126.89 3.38 6.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.677 1.235 . . . . 0.0 112.121 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.9 t -88.33 36.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 51.99 19.09 0.92 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.974 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.63 -36.29 69.29 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.448 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 44' ' ' CYS . 3.4 t -139.9 -122.63 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' H ' HG23 ' A' ' 43' ' ' THR . 31.9 t 64.88 30.38 12.08 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.202 1.001 . . . . 0.0 113.661 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -79.89 89.53 5.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 47' ' ' VAL . 34.9 t 53.5 37.85 26.69 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.472 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 46' ' ' SER . 14.0 p 55.65 -21.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 C-N-CA 128.593 2.757 . . . . 0.0 115.072 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' SER . 59.9 p -89.25 42.07 1.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 55' ' ' SER . 28.3 p 43.4 -174.07 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 52' ' ' GLY . 86.4 tttt -37.14 133.32 0.66 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.6 t -89.7 31.88 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.734 1.254 . . . . 0.0 108.751 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -126.94 -38.26 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -79.21 165.19 23.53 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.802 0.81 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 t80 -86.54 75.43 9.73 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.683 -1.599 . . . . 0.0 114.624 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.463 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . 69.8 p -82.89 103.14 12.14 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 56.2 m -58.81 -42.37 89.0 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.37 -165.14 1.4 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 124.131 0.895 . . . . 0.0 113.076 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 -89.14 0.15 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HG3' HG22 ' A' ' 60' ' ' VAL . 27.9 ptt-85 -75.57 -43.27 49.36 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.086 -1.057 . . . . 0.0 108.223 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 59' ' ' ARG . 32.9 m -146.2 131.9 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.574 0.546 . . . . 0.0 109.9 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.11 62.26 4.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 3.3 tpm_? -91.39 109.01 20.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.619 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.5 m -79.36 115.19 18.85 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 39.8 mm -106.97 131.42 21.7 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.003 -1.908 . . . . 0.0 109.57 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.6 104.63 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 N-CA-C 106.869 -2.012 . . . . 0.0 106.869 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -18.15 -40.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -64.32 -4.71 4.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 118.123 -1.431 . . . . 0.0 112.458 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -89.57 10.96 21.05 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 58.3 ttt85 -80.38 140.51 36.02 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.336 0.589 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 14.2 t 53.89 35.48 21.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.509 -1.678 . . . . 0.0 107.979 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -91.7 -9.83 42.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 82' ' ' GLU . . . 77.39 -38.19 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.47 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.16 101.96 9.11 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.85 140.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 125.817 1.948 . . . . 0.0 114.733 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -132.98 -43.0 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.593 -2.094 . . . . 0.0 106.13 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.1 m -85.42 151.99 23.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.688 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -45.44 -38.98 6.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.96 0.787 . . . . 0.0 112.846 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.44 -10.25 15.31 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.981 0.801 . . . . 0.0 110.369 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 55.25 15.73 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.9 m -75.02 22.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.812 -1.194 . . . . 0.0 112.341 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 15.9 p-10 -140.73 15.75 2.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.992 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 16.8 mm-40 -126.32 -64.56 1.03 Allowed 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -82.64 -36.19 26.26 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.452 -2.796 . . . . 0.0 103.452 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.91 55.41 5.03 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.245 1.021 . . . . 0.0 113.348 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -143.62 125.48 15.18 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 178.07 9.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.005 0.816 . . . . 0.0 110.252 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.89 -35.3 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.859 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.42 23.67 77.34 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.313 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.6 148.66 51.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.985 0.462 . . . . 0.0 111.354 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -79.74 179.57 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.621 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . 68.0 m -94.99 179.69 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.639 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -158.35 49.93 0.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.4 -122.15 0.1 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.1 p30 -98.82 -0.91 41.57 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 37.4 mt-10 -79.56 154.51 28.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.966 1.365 . . . . 0.0 113.285 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -91.15 119.57 31.37 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.87 132.23 35.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 37' ' ' SER . 42.6 t -74.18 174.93 8.04 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.3 1.048 . . . . 0.0 110.677 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 32.1 tt0 -75.2 -29.1 60.24 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.3 t70 -78.06 -18.88 55.24 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.447 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.59 -13.72 59.46 Favored Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.726 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.36 120.73 11.58 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.11 0.481 . . . . 0.0 111.576 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 15.7 t -84.92 119.8 25.77 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.519 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -132.1 153.3 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 59.5 m -83.29 175.44 9.9 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 26' ' ' VAL . 33.9 m-85 -59.72 -33.76 72.04 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.575 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.3 m95 -86.0 -18.44 32.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.284 -1.326 . . . . 0.0 112.895 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 23' ' ' TYR . 32.8 m -95.24 143.23 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.7 t 47.08 37.11 4.85 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.127 -2.306 . . . . 0.0 113.363 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -90.59 20.3 4.73 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.998 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.19 -14.14 58.18 Favored Glycine 0 N--CA 1.485 1.964 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.715 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -132.77 168.43 18.36 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.605 0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.12 114.92 29.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.979 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 12.5 mp0 -94.95 -10.01 32.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.6 t -93.15 -15.4 26.04 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.963 0.789 . . . . 0.0 110.661 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 72.45 32.67 1.56 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.93 1.394 . . . . 0.0 109.188 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.49 -51.2 0.69 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 112.458 -2.156 . . . . 0.0 106.795 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 116.75 -3.55 19.52 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.482 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -46.32 -58.18 3.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.866 0.98 . . . . 0.0 111.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.05 -23.08 67.28 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.427 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -102.51 2.51 36.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.255 1.597 . . . . 0.0 112.187 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLY . 37.5 t -89.85 34.16 0.85 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.693 0.758 . . . . 0.0 112.095 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 7.7 tt0 44.54 29.81 0.44 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.3 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -58.09 -37.86 75.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.553 1.168 . . . . 0.0 108.334 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 44' ' ' CYS . 1.6 t -126.23 -100.78 0.37 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.6 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 43' ' ' THR . 9.8 t 63.31 48.31 3.66 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.974 1.309 . . . . 0.0 108.714 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.55 -22.88 9.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.792 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -85.93 -100.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.52 147.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 123.091 0.244 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t 34.42 49.11 0.32 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 124.836 1.335 . . . . 0.0 112.623 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 p -63.02 168.13 4.29 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.893 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HE3' ' SG ' ' A' ' 44' ' ' CYS . 18.4 ptpt -131.42 -154.98 0.66 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.074 -1.875 . . . . 0.0 110.379 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.8 t 63.74 41.91 6.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.5 1.125 . . . . 0.0 111.433 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.16 22.76 0.57 Allowed Glycine 0 N--CA 1.5 2.926 0 CA-C-N 113.344 -1.753 . . . . 0.0 117.14 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -79.82 169.0 18.55 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 117.537 0.669 . . . . 0.0 111.804 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 40.6 t80 -79.93 168.17 19.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.085 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 46.1 t -154.92 117.43 4.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.52 -65.48 0.67 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.19 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.96 -178.28 40.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.14 -115.53 5.24 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.638 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -31.35 -45.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 125.259 1.211 . . . . 0.0 113.801 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.61 -163.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -153.81 95.07 1.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -166.25 130.93 2.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -80.05 133.03 36.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.989 -1.914 . . . . 0.0 108.288 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 37.0 mm -113.76 137.16 22.15 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 10.8 Cg_endo -56.14 144.12 81.74 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 N-CA-C 106.969 -1.974 . . . . 0.0 106.969 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -57.18 -32.41 66.41 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.563 -1.255 . . . . 0.0 107.961 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -54.43 -25.16 23.29 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.716 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 51.7 m0 -111.02 41.87 1.74 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -130.6 119.73 22.93 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.8 t 69.05 45.91 0.87 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 126.762 2.025 . . . . 0.0 108.354 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' OD2' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -107.53 4.15 25.76 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.078 -1.873 . . . . 0.0 112.135 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.77 -39.18 2.54 Favored Glycine 0 CA--C 1.547 2.04 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.35 107.01 11.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' A' ' 79' ' ' GLY . 70.5 t -60.11 136.91 23.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.84 -40.13 2.46 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 96.2 m -80.17 162.83 24.5 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.68 -38.81 67.42 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.974 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -112.78 4.41 17.01 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 55.83 42.48 85.96 Favored Glycine 0 N--CA 1.494 2.541 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.578 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB2' ' NH2' ' A' ' 59' ' ' ARG . 52.0 m -77.85 33.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 79' ' ' GLY . 13.2 p-10 -124.62 -35.53 2.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.99 -57.83 2.6 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -70.81 -44.1 67.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.33 58.12 3.11 Favored Glycine 0 N--CA 1.484 1.895 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.404 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.656 1.217 . . . . 0.0 112.863 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -140.6 44.59 1.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.418 0.627 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.16 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.23 150.11 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.721 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.33 41.2 99.45 Favored Glycine 0 N--CA 1.498 2.782 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.342 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.72 129.86 40.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -87.12 -175.82 5.47 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 69.8 m -142.6 168.35 19.93 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.851 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.6 pt-20 -152.54 44.72 0.7 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.814 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.69 -121.68 0.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.454 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.3 OUTLIER -92.8 5.59 50.64 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 29.4 mt-10 -98.63 146.73 25.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.614 1.197 . . . . 0.0 110.242 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -88.31 120.64 29.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 111.91 -2.405 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -85.63 129.74 34.75 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.9 t -73.5 176.22 6.31 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.357 1.075 . . . . 0.0 112.354 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 54.3 tp60 -74.6 -30.37 61.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 102.356 -3.202 . . . . 0.0 102.356 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.8 t70 -79.0 -17.81 54.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.121 -2.309 . . . . 0.0 106.784 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 97.78 -11.17 64.53 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.211 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -61.48 123.92 19.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.126 0.545 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.2 t -85.77 123.79 31.54 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.569 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -138.33 149.14 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.3 m -80.43 167.14 20.53 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.311 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' VAL . 59.5 m-85 -58.69 -36.15 73.76 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.37 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -50.07 -27.1 5.11 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.568 ' HB2' HD13 ' A' ' 21' ' ' ILE . 5.1 m95 -82.97 -36.5 25.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.677 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 23' ' ' TYR . 20.1 m -69.28 139.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.5 t 42.15 40.41 1.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 111.305 -2.68 . . . . 0.0 112.066 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -81.28 -24.69 37.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.335 -1.757 . . . . 0.0 111.584 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.17 -15.18 1.9 Allowed Glycine 0 N--CA 1.485 1.927 0 O-C-N 124.076 0.86 . . . . 0.0 111.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 t -145.65 171.43 14.74 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.655 0.74 . . . . 0.0 110.669 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.2 105.31 17.34 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.793 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -79.25 -25.5 42.56 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.448 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 39.1 t -78.11 -16.15 58.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.458 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.56 46.56 5.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 101.952 -3.351 . . . . 0.0 101.952 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.3 -53.82 0.46 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 112.05 -1.86 27.03 Favored Glycine 0 C--O 1.207 -1.536 0 N-CA-C 106.756 -2.538 . . . . 0.0 106.756 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 33.0 t -50.58 -58.55 5.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.611 0.83 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -63.77 -19.49 65.03 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.419 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -106.04 3.38 28.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.687 1.242 . . . . 0.0 111.899 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 36' ' ' GLY . 48.5 t -87.67 31.09 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.168 0.985 . . . . 0.0 112.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 51.48 10.14 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.623 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -49.37 -34.93 17.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 t -151.0 51.04 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.612 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.5 t -80.94 -6.05 58.23 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.6 mm? -79.11 -36.2 41.03 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 123.86 0.725 . . . . 0.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -68.2 -179.31 1.23 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.146 0.904 . . . . 0.0 111.678 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 p 36.17 47.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 124.925 1.391 . . . . 0.0 112.291 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.5 m 53.7 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 53' ' ' ASP . 30.1 p -46.34 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.356 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 4.4 ttmp? -151.0 63.5 0.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 113.212 -1.813 . . . . 0.0 106.842 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.3 t -152.48 50.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.891 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.77 22.4 Favored Glycine 0 N--CA 1.502 3.06 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.775 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 6.6 m-20 -80.92 163.05 23.63 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.216 0.531 . . . . 0.0 111.015 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.522 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 49.5 t80 -87.34 101.72 13.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.248 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.5 p -83.97 117.88 23.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.44 -58.69 5.14 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.39 -154.96 26.11 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.824 -1.179 . . . . 0.0 114.114 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.38 -30.86 32.36 Favored Glycine 0 N--CA 1.495 2.573 0 CA-C-N 114.072 -1.064 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -59.15 -45.57 90.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 59' ' ' ARG . 34.1 m -139.35 130.9 34.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.77 85.7 3.37 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -146.91 128.37 14.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 112.715 -2.038 . . . . 0.0 113.461 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.1 m -78.87 141.58 37.54 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 112.04 -2.346 . . . . 0.0 107.712 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 29.0 mm -126.39 139.35 34.39 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 124.727 1.267 . . . . 0.0 107.84 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.63 108.08 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -24.52 -39.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -65.69 -2.4 3.58 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 117.996 -1.482 . . . . 0.0 112.131 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASP . 26.4 m0 -86.9 4.75 40.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.63 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -88.45 145.7 25.62 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 18.4 t 45.59 39.65 5.1 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 68' ' ' TRP . 7.1 t70 -94.38 4.9 53.25 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.2 -6.06 0.12 Allowed Glycine 0 N--CA 1.496 2.658 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.498 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' ASP . 14.3 tt0 -130.56 104.24 7.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.992 0.396 . . . . 0.0 110.336 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.49 135.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.868 0.842 . . . . 0.0 112.298 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -116.72 -40.85 3.12 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.755 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' A' ' 64' ' ' ILE . 93.4 m -91.62 163.42 14.12 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.935 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -52.59 -52.43 55.21 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.843 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -88.5 -19.55 26.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.792 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 71.34 50.6 20.76 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.135 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -76.2 6.58 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.794 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 79' ' ' GLY . 2.1 p30 -111.11 -8.06 14.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.439 1.896 . . . . 0.0 108.469 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 4.4 tp10 -98.73 -59.57 1.71 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 101.347 -3.575 . . . . 0.0 101.347 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.04 -31.82 70.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 112.094 -2.321 . . . . 0.0 105.941 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -41.17 -11.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 CA-C-N 111.278 -2.692 . . . . 0.0 118.17 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 122.159 0.981 . . . . 0.0 112.262 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 49.06 42.66 21.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.42 0.718 . . . . 0.0 111.989 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.23 91.84 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.417 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 5' ' ' GLY . 61.7 t 61.04 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 4' ' ' VAL . . . -161.58 -73.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -117.77 88.84 2.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -97.96 -175.68 3.22 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.111 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 94.9 m -108.47 176.0 5.27 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.455 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.4 pt-20 -147.35 42.82 1.1 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.33 -117.78 0.11 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.73 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.435 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.2 p30 -107.9 15.03 24.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 45.5 mt-10 -86.3 161.93 18.5 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.218 1.009 . . . . 0.0 113.032 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -97.0 114.95 26.6 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.487 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.09 132.33 36.56 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 46.1 t -71.92 175.62 5.69 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.468 1.128 . . . . 0.0 111.63 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 tt0 -73.11 -31.84 64.59 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.08 -18.81 59.03 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.189 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.19 -12.67 60.35 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -66.35 114.63 5.54 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.846 -0.677 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 21.7 t -81.17 128.37 33.69 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.6 1.191 . . . . 0.0 113.086 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -135.29 151.99 31.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 111.821 -2.445 . . . . 0.0 105.536 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -77.52 172.02 14.0 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.362 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 m-85 -62.35 -27.97 69.43 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.388 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -63.6 -22.93 67.16 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.538 ' HB2' HD13 ' A' ' 21' ' ' ILE . 9.6 m95 -87.48 -12.75 45.09 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.469 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 23' ' ' TYR . 24.0 m -104.03 149.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 119.369 0.986 . . . . 0.0 112.996 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 t 42.84 38.23 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -98.63 25.91 6.05 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.864 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.56 -7.8 23.62 Favored Glycine 0 N--CA 1.487 2.047 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.269 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.3 t -132.67 165.36 24.64 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.693 0.759 . . . . 0.0 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.04 119.79 39.9 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.175 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 10.8 mp0 -102.32 -24.09 13.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.981 0.801 . . . . 0.0 112.675 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.68 -5.72 53.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 123.576 0.547 . . . . 0.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 61.26 37.16 17.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.99 -53.55 0.75 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 112.724 -2.035 . . . . 0.0 105.513 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 114.61 -7.67 22.28 Favored Glycine 0 C--O 1.21 -1.367 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -42.33 -60.42 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.552 1.168 . . . . 0.0 112.43 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 26' ' ' VAL . 4.4 p-10 -60.0 -29.75 68.67 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.84 -2.436 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -95.9 -0.92 50.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 125.212 1.57 . . . . 0.0 112.516 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLY . 39.4 t -90.06 40.3 1.0 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.817 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 36.44 31.81 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -61.06 -37.14 81.59 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -124.96 -146.51 0.35 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 44.6 t 45.65 20.27 0.06 Allowed 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 122.065 0.935 . . . . 0.0 111.752 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.4 tp -163.51 -53.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.088 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -87.18 62.03 7.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.536 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -170.46 174.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 112.701 -2.045 . . . . 0.0 105.572 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -70.01 74.74 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.492 0.663 . . . . 0.0 110.02 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.8 m -154.52 168.62 26.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.919 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 51' ' ' SER . 3.4 tmmm? -141.14 152.17 44.49 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.461 ' N ' ' HD2' ' A' ' 50' ' ' LYS . 80.2 p -82.54 25.98 0.6 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.27 -8.79 0.33 Allowed Glycine 0 N--CA 1.502 3.087 0 CA-C-N 113.679 -1.601 . . . . 0.0 113.55 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.47 179.11 5.62 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 55' ' ' SER . 11.1 t80 -76.33 167.57 21.61 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.566 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 67.3 m -153.3 120.65 5.86 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 69.9 m -70.5 -41.33 72.78 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.73 -178.02 1.27 Allowed Glycine 0 N--CA 1.488 2.104 0 CA-C-N 113.647 -1.615 . . . . 0.0 115.408 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.64 -94.68 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 CA-C-N 113.619 -1.29 . . . . 0.0 111.152 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -61.59 -45.13 95.44 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.189 -1.005 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.08 129.49 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 123.912 0.758 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.437 ' H ' ' ND2' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -89.68 58.47 4.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.87 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.6 ttp85 -116.5 119.12 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.7 m -81.29 134.34 35.57 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.795 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 32.1 mm -109.26 141.42 23.44 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.84 137.1 77.62 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -49.06 -48.15 44.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -58.66 -11.23 2.86 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.982 -1.087 . . . . 0.0 113.791 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -78.9 7.0 7.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -82.43 146.95 29.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.4 t 44.13 35.53 1.23 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 122.758 1.266 . . . . 0.0 109.021 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.78 0.87 51.73 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.93 -27.52 0.77 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.878 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.68 105.71 16.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.25 133.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.655 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -121.58 -41.83 2.46 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.101 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 54' ' ' PHE . 93.8 m -82.46 142.89 31.54 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.06 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.4 -38.7 84.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.7 -27.9 61.45 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 67.51 28.03 73.58 Favored Glycine 0 N--CA 1.489 2.207 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.719 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 59.8 p -72.8 21.72 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 79' ' ' GLY . 19.8 p-10 -124.25 2.17 8.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.571 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.27 -61.31 0.78 Allowed 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.58 -38.85 65.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 111.47 -2.605 . . . . 0.0 104.575 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.27 1.93 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 112.111 -2.313 . . . . 0.0 112.437 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 122.433 1.111 . . . . 0.0 112.264 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m 54.53 -151.0 0.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.35 0.676 . . . . 0.0 111.349 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.76 63.19 2.33 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.756 0.788 . . . . 0.0 111.814 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.73 -34.84 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.19 59.95 2.09 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 123.721 0.638 . . . . 0.0 113.432 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 72.71 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.53 0.681 . . . . 0.0 110.418 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -94.08 167.21 11.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.38 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 85.7 m -125.4 171.46 10.43 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.753 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.5 pt-20 -144.53 41.88 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.2 -117.86 0.12 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.844 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -112.35 11.52 20.04 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 45.7 mt-10 -78.31 161.07 27.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.652 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.0 109.26 20.31 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 112.679 -2.055 . . . . 0.0 112.412 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -79.93 131.88 35.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -71.75 174.14 7.24 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.28 1.038 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 30.7 tp60 -74.41 -28.73 61.21 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -75.75 -21.39 57.51 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 111.627 -2.533 . . . . 0.0 106.598 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.18 -11.17 60.22 Favored Glycine 0 N--CA 1.497 2.759 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.222 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.27 114.78 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.501 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 37.1 t -85.07 131.24 34.48 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.663 1.22 . . . . 0.0 112.877 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -134.14 153.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 111.642 -2.526 . . . . 0.0 105.293 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -85.1 168.46 14.83 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' O ' HG22 ' A' ' 26' ' ' VAL . 44.0 m-85 -54.86 -41.19 70.51 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HZ3' ' HE1' ' A' ' 25' ' ' TRP . 25.2 pttm -56.08 -15.86 4.24 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.01 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.564 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.6 m95 -87.0 -37.25 17.69 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.451 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 23' ' ' TYR . 16.8 m -74.37 144.29 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t 41.42 42.02 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 111.629 -2.532 . . . . 0.0 113.961 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.43 -39.77 31.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.581 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.09 -13.87 0.98 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.722 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 t -131.31 168.57 17.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.266 1.032 . . . . 0.0 111.596 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.18 111.44 23.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.214 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 15.8 mp0 -88.43 -23.6 23.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.81 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 42.8 t -77.74 -18.87 56.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.845 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 74.09 32.33 1.05 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 125.364 1.665 . . . . 0.0 107.826 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -134.54 -52.35 0.81 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.35 -2.205 . . . . 0.0 106.182 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 117.54 -1.1 18.33 Favored Glycine 0 C--O 1.209 -1.44 0 N-CA-C 108.339 -1.905 . . . . 0.0 108.339 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.4 t -48.78 -58.1 5.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 124.692 0.878 . . . . 0.0 110.889 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -64.42 -18.39 64.68 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.984 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -107.13 2.97 25.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 125.006 1.441 . . . . 0.0 111.808 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' GLY . 36.4 t -90.28 30.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.747 0.784 . . . . 0.0 112.153 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 43.05 36.28 0.9 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.344 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.62 -45.52 92.46 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 44' ' ' CYS . 3.0 t -114.14 -119.33 0.31 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 112.499 -2.137 . . . . 0.0 106.561 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.404 ' H ' HG23 ' A' ' 43' ' ' THR . 12.2 t 64.56 43.72 4.29 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.884 1.274 . . . . 0.0 111.987 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -85.69 68.12 10.29 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' THR . 40.2 t 60.05 88.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.361 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 48' ' ' THR . 7.7 p 38.36 -60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.641 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 ' H ' HG13 ' A' ' 47' ' ' VAL . 34.6 p -76.8 49.56 0.64 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.507 0.723 . . . . 0.0 111.554 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.5 p 37.46 -153.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.392 1.477 . . . . 0.0 113.207 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.52 139.26 20.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.4 t -88.25 31.85 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.158 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.95 -34.07 1.19 Allowed Glycine 0 N--CA 1.495 2.594 0 CA-C-N 112.615 -2.084 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.51 170.36 16.69 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.691 ' CE2' ' SG ' ' A' ' 56' ' ' CYS . 36.7 t80 -77.05 80.56 3.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.677 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 t -83.83 117.6 23.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.691 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 59.4 m -77.51 -39.14 47.26 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.329 -1.348 . . . . 0.0 112.708 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.01 -173.14 0.65 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 124.551 1.157 . . . . 0.0 114.407 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.81 -95.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.614 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -57.47 -45.04 85.28 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.514 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.21 125.14 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -93.41 76.49 4.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -151.93 135.66 16.29 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.075 -1.875 . . . . 0.0 115.878 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.8 m -79.47 140.6 37.27 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 111.167 -2.742 . . . . 0.0 109.349 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 28.8 mm -131.09 135.68 27.63 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 68' ' ' TRP . 37.5 Cg_exo -58.83 137.45 80.0 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 108.042 -1.561 . . . . 0.0 108.042 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.68 -39.09 61.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -63.0 -10.39 13.62 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.544 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.413 ' HB2' HG22 ' A' ' 64' ' ' ILE . 18.5 m0 -79.27 6.78 9.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -81.13 141.73 33.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.96 37.89 11.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.834 1.334 . . . . 0.0 107.774 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.75 1.33 55.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.55 -21.83 0.42 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.442 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -106.95 106.97 17.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 117.52 0.66 . . . . 0.0 112.351 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.14 136.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.351 1.032 . . . . 0.0 112.477 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -126.14 -41.36 1.93 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.305 -1.771 . . . . 0.0 106.297 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.56 142.28 27.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.033 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -32.36 -72.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.62 -25.05 61.16 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 84.79 52.81 3.37 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.649 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 m -76.38 25.98 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.355 1.074 . . . . 0.0 112.068 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 18.3 p-10 -132.7 2.74 3.77 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.058 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -129.09 -61.54 1.03 Allowed 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.54 -37.37 63.05 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.53 36.3 1.38 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 112.014 -2.357 . . . . 0.0 113.077 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.351 1.072 . . . . 0.0 112.215 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 156.22 46.42 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.885 -0.658 . . . . 0.0 109.567 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.79 86.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.534 1.147 . . . . 0.0 111.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -70.69 -163.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.379 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.58 28.43 72.29 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.5 85.3 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.576 0.703 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -92.44 168.27 11.39 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.724 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 68.5 m -139.94 173.45 11.51 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.468 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.09 43.91 1.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -140.68 -118.78 0.12 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.94 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 5.5 p30 -102.79 2.08 35.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.3 mt-10 -79.38 154.9 28.67 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.191 0.996 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -92.64 119.51 32.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 112.645 -2.071 . . . . 0.0 112.411 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -83.0 131.71 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 49.0 t -74.25 177.45 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.381 1.086 . . . . 0.0 111.788 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.53 -34.31 62.97 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -74.27 -16.49 60.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.542 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.39 -10.01 69.32 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 40.0 ttmt -63.59 122.74 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.473 0.749 . . . . 0.0 109.207 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 26.9 t -85.03 117.66 24.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.256 1.026 . . . . 0.0 112.557 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -125.37 153.5 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 37.0 t -84.91 175.64 8.97 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . 3.3 m-85 -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.594 -0.843 . . . . 0.0 112.124 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.09 -24.62 67.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.479 ' HB2' HD13 ' A' ' 21' ' ' ILE . 8.3 m95 -86.76 -5.26 59.17 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 113.919 -1.491 . . . . 0.0 113.1 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 23' ' ' TYR . 34.7 m -109.03 142.48 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.031 1.287 . . . . 0.0 113.358 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.1 t 42.91 41.42 2.58 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.387 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.71 21.3 9.61 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.328 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.91 10.86 85.93 Favored Glycine 0 N--CA 1.486 1.996 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.631 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 t -155.5 161.69 40.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.151 0.977 . . . . 0.0 110.052 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.29 117.85 35.64 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.092 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.8 mp0 -98.87 -25.17 14.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.871 0.732 . . . . 0.0 112.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 42.1 t -79.78 6.97 9.54 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.896 0.855 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 63.55 34.27 12.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.447 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -151.03 -56.58 0.16 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 136.1 7.0 1.83 Allowed Glycine 0 C--O 1.209 -1.412 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 47.9 t -49.94 -59.05 4.23 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.839 0.828 . . . . 0.0 110.424 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -65.5 -19.0 65.75 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.566 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -102.7 1.29 34.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 125.061 1.476 . . . . 0.0 111.588 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.1 t -86.43 29.12 0.79 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.961 0.886 . . . . 0.0 111.041 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 38.98 37.74 0.24 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.056 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.36 -46.42 90.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 45' ' ' LEU . 4.3 t -107.09 -127.81 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.169 -2.159 . . . . 0.0 105.169 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t 62.95 28.7 16.4 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.741 1.217 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -78.83 90.34 4.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.3 m 66.5 -76.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.389 1.68 . . . . 0.0 108.088 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -171.94 -28.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.2 p -81.96 34.7 0.41 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.455 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p 37.29 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 52' ' ' GLY . 28.9 mtpp -29.72 123.7 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 124.579 1.174 . . . . 0.0 112.668 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -82.62 27.44 0.52 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . -124.92 -33.02 0.76 Allowed Glycine 0 N--CA 1.495 2.606 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.26 173.68 10.18 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 37.9 t80 -88.66 101.33 13.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.2 t -89.28 109.71 20.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 64.0 m -45.21 -48.79 12.57 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.274 0.984 . . . . 0.0 109.912 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.85 175.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 O-C-N 125.057 1.473 . . . . 0.0 116.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.74 -90.71 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 CA-C-N 113.375 -1.413 . . . . 0.0 112.429 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 60' ' ' VAL . 8.1 ptp85 -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.487 -0.857 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.5 m -143.18 146.76 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -101.55 69.42 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 22.3 tpp85 -109.9 146.52 35.0 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.489 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 54.2 m -101.88 123.17 45.36 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.0 mm -117.7 138.26 25.07 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 113.383 -1.735 . . . . 0.0 108.597 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 29.3 Cg_endo -65.02 138.02 55.16 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.81 -30.51 33.78 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 121.829 0.823 . . . . 0.0 109.747 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -50.05 -31.95 14.27 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.239 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.417 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 50.9 m0 -90.56 22.87 3.26 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -79.95 124.07 28.36 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.4 t 56.07 32.96 21.02 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 123.14 1.448 . . . . 0.0 109.028 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -85.1 -6.83 59.29 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.233 -2.258 . . . . 0.0 116.851 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 -34.64 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 115.099 0.8 . . . . 0.0 115.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -78.78 106.5 10.83 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.61 131.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 125.129 1.518 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' HB3' HD12 ' A' ' 64' ' ' ILE . 64.9 m-20 -125.45 -40.94 2.06 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.417 -2.174 . . . . 0.0 107.227 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 64' ' ' ILE . 94.6 m -88.9 165.91 14.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.992 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.08 -67.12 0.28 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 123.916 0.76 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -86.06 -14.11 45.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.924 0.765 . . . . 0.0 109.509 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 78.34 57.03 3.49 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.29 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 70.9 m -70.31 14.35 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 9.4 p-10 -134.86 18.84 3.5 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.178 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 mp0 -139.53 -63.32 0.51 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 101.69 -3.448 . . . . 0.0 101.69 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.0 -38.85 43.93 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -85.08 47.17 3.8 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.235 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 124.011 1.862 . . . . 0.0 111.976 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -70.1 158.81 35.05 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.947 0.44 . . . . 0.0 110.618 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.11 147.81 27.53 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.64 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 5' ' ' GLY . 9.7 p 32.95 -119.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.98 1.425 . . . . 0.0 113.376 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.455 ' H ' HG13 ' A' ' 4' ' ' VAL . . . 93.94 -23.76 29.61 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -133.08 78.24 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.392 0.615 . . . . 0.0 111.59 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -95.0 176.62 6.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.6 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 92.2 m -90.11 172.73 8.61 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.577 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.3 pt-20 -151.48 45.07 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -142.09 -117.97 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.076 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.36 10.79 27.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 43.8 mt-10 -79.1 156.19 28.42 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.758 1.266 . . . . 0.0 113.588 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -88.18 112.29 22.57 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.314 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.06 130.76 35.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.5 t -70.72 176.06 4.48 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.509 1.147 . . . . 0.0 112.081 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.501 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 tm0? -74.06 -33.34 63.65 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 27.1 t70 -75.1 -17.81 60.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 112.859 -1.973 . . . . 0.0 107.501 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.02 -9.74 61.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 4.1 tppp? -64.38 113.01 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.476 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 20.2 t -83.35 128.44 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.311 1.053 . . . . 0.0 113.296 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -138.71 151.92 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.347 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.6 m -80.62 168.25 19.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 123.636 0.585 . . . . 0.0 112.315 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' VAL . 47.7 m-85 -58.18 -37.31 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.645 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -51.28 -26.52 7.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.6 m95 -83.19 -36.51 24.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.154 -1.384 . . . . 0.0 112.229 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' TYR . 17.4 m -74.99 152.62 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.827 -1.149 . . . . 0.0 113.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.6 t 49.63 38.01 14.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 112.759 -2.019 . . . . 0.0 114.86 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -99.06 26.46 5.82 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.37 17.04 63.61 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.4 t -151.12 165.11 34.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.169 0.985 . . . . 0.0 110.763 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.53 111.37 23.61 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.919 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 8.1 mp0 -91.89 -12.67 32.9 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.153 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.5 t -94.75 -7.73 39.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.23 0.956 . . . . 0.0 112.215 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 58.97 29.66 19.24 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 123.113 1.435 . . . . 0.0 107.478 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.75 -53.5 1.33 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.5 2.23 32.92 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 37.8 t -53.95 -55.24 28.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.756 0.916 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.27 -9.07 10.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.149 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -122.81 3.21 9.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.508 1.13 . . . . 0.0 111.849 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' GLY . 43.4 t -87.65 40.21 0.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.637 0.732 . . . . 0.0 112.015 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 50.8 21.95 1.04 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.34 -37.3 85.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.004 0.907 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -152.2 30.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.661 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -92.64 25.56 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.274 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.8 mm? -103.76 -32.39 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.149 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -100.93 -177.06 3.35 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.489 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p 34.17 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p 33.43 48.5 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.706 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 p -40.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.517 -2.129 . . . . 0.0 116.09 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 52.63 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.895 0.747 . . . . 0.0 111.295 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -146.59 34.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.016 0.912 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.49 2.64 69.13 Favored Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.949 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 63' ' ' CYS . 1.1 m-20 -79.69 164.5 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.776 0.798 . . . . 0.0 111.588 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' A' ' 76' ' ' CYS . 71.5 t80 -68.59 106.02 2.45 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.38 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.0 p -81.91 122.54 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 72.6 m -56.85 -63.16 1.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.757 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.3 -155.76 27.25 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.638 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.26 -34.28 55.16 Favored Glycine 0 N--CA 1.495 2.596 0 CA-C-N 114.318 -0.941 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG3' HG22 ' A' ' 60' ' ' VAL . 11.4 ptp180 -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.5 m -140.87 123.45 15.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.95 78.18 5.36 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -147.26 135.28 21.39 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.934 -1.939 . . . . 0.0 115.015 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 98.4 m -78.68 144.85 34.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.12 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.567 HG13 ' SG ' ' A' ' 76' ' ' CYS . 34.7 mm -127.17 128.33 24.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 51.7 Cg_exo -48.08 146.1 9.77 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 CA-C-N 120.394 1.177 . . . . 0.0 109.698 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' TRP . 32.3 tt0 -64.31 -37.43 87.47 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.161 -1.816 . . . . 0.0 109.48 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.51 1.3 3.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLN . 18.4 m0 -110.89 30.12 7.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 37.0 ttm180 -122.57 130.24 52.8 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.1 t 57.9 45.52 18.21 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 122.526 1.155 . . . . 0.0 108.139 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -102.67 8.02 39.7 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.457 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.21 -32.24 2.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' ASP . 20.9 tt0 -93.12 105.48 17.56 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.706 0.765 . . . . 0.0 113.061 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 79' ' ' GLY . 73.2 t -62.37 125.49 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -108.88 -39.0 5.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.166 -1.833 . . . . 0.0 108.315 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG13 ' A' ' 64' ' ' ILE . 76.7 m -80.53 157.07 26.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.557 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -46.1 -43.56 14.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.882 1.364 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -105.64 -24.13 12.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.675 1.234 . . . . 0.0 109.978 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 80.68 42.43 10.01 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 123.815 0.697 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.2 p -78.19 30.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.617 1.675 . . . . 0.0 114.058 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -120.46 -38.88 2.83 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 110.558 -3.019 . . . . 0.0 105.101 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -56.24 3.4 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.34 -40.91 57.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.97 56.8 3.3 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.387 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 122.754 1.264 . . . . 0.0 113.492 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -63.76 -36.82 85.13 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.028 0.487 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.33 53.22 12.24 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.449 1.093 . . . . 0.0 112.298 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -73.73 162.5 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.755 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.43 -9.37 61.21 Favored Glycine 0 N--CA 1.498 2.827 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.237 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 134.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -97.89 168.46 10.29 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.651 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.6 m -134.0 168.19 19.25 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.773 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 10.8 pt-20 -145.87 42.09 1.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.845 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -136.81 -119.59 0.15 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.314 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.53 16.71 22.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 32.7 mt-10 -105.47 152.49 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.244 1.021 . . . . 0.0 110.41 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -90.32 119.89 31.0 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 112.65 -2.068 . . . . 0.0 111.788 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -84.47 133.65 34.47 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 44.8 t -77.16 176.3 8.86 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.235 1.017 . . . . 0.0 110.29 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 23.0 tt0 -75.09 -29.38 60.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.99 -17.04 56.08 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.199 -2.273 . . . . 0.0 107.161 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.28 -16.74 57.78 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -56.63 121.8 10.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.159 0.564 . . . . 0.0 111.711 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 36.3 t -88.22 127.07 35.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.963 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.576 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.9 pp -141.89 149.95 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.7 m -77.78 165.62 23.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.77 0.669 . . . . 0.0 112.127 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 26' ' ' VAL . 74.0 m-85 -57.54 -36.84 72.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.251 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -50.23 -24.96 3.19 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.539 0.685 . . . . 0.0 109.557 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.8 m95 -85.2 -38.13 19.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.284 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 23' ' ' TYR . 15.7 m -72.32 145.11 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.8 t 42.34 41.71 2.31 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 111.805 -2.452 . . . . 0.0 111.735 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -86.87 -26.91 23.74 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.49 -18.79 1.68 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 124.056 0.847 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -140.74 171.36 14.2 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.776 0.798 . . . . 0.0 111.338 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.86 103.14 15.01 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.685 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -81.01 -22.15 39.63 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.5 t -78.03 -18.69 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.621 0.576 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 74.29 39.96 0.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -142.16 -51.32 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.265 -1.789 . . . . 0.0 106.772 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 118.06 -5.27 15.85 Favored Glycine 0 C--O 1.208 -1.472 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 t -46.22 -60.15 2.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.066 0.936 . . . . 0.0 111.21 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.06 -24.57 66.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.363 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -103.43 1.28 32.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 125.043 1.464 . . . . 0.0 113.059 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 40.0 t -89.35 28.91 1.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.842 0.83 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 46.38 28.8 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.88 -31.35 66.64 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 45' ' ' LEU . 3.1 t -129.67 -120.71 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 111.125 -2.761 . . . . 0.0 105.039 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' H ' HG23 ' A' ' 43' ' ' THR . 10.6 t 82.17 -22.85 0.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.575 1.95 . . . . 0.0 109.916 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -78.92 20.08 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.771 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.9 m -103.25 -61.57 1.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.85 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 124.314 1.009 . . . . 0.0 113.322 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.1 m 47.96 36.3 6.03 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.72 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.4 m -130.11 163.08 27.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.385 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.85 32.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p 43.11 37.07 1.07 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.548 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.48 15.57 0.32 Allowed Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.68 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -116.35 164.08 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.701 1.238 . . . . 0.0 114.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.704 ' CE2' ' SG ' ' A' ' 76' ' ' CYS . 21.6 t80 -72.56 86.78 1.19 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 111.658 -2.519 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 t -75.86 116.79 16.93 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.3 m -54.25 -49.94 68.36 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.06 159.64 0.06 OUTLIER Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.51 1.131 . . . . 0.0 114.672 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.54 -91.58 0.4 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -49.29 -45.44 45.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.65 0.853 . . . . 0.0 111.899 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.15 -165.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -145.93 91.9 2.14 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -168.52 129.55 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.26 139.82 36.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.51 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 42.9 mm -117.28 124.12 29.35 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.9 108.3 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 N-CA-C 109.322 -1.069 . . . . 0.0 109.322 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -28.27 -35.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 119.066 2.988 . . . . 0.0 119.066 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -64.23 -3.93 3.24 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.781 1.628 . . . . 0.0 111.303 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -85.19 10.02 13.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -85.73 140.79 30.2 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 t 51.48 31.55 7.6 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.596 1.188 . . . . 0.0 108.055 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.95 -0.34 53.95 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.82 -31.64 1.05 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -95.89 102.7 14.53 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.38 129.18 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.006 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -116.82 -40.4 3.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.74 -1.573 . . . . 0.0 106.984 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 90.2 m -94.51 138.84 31.92 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.06 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.84 -50.15 66.84 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -62.99 -18.61 63.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.911 0.757 . . . . 0.0 109.496 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 62.39 36.8 93.62 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 84' ' ' GLY . 69.7 m -74.7 21.93 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.991 0.9 . . . . 0.0 112.991 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 20.7 p-10 -131.27 4.61 4.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.119 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -133.65 -61.27 0.81 Allowed 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.68 -35.98 51.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.979 -2.373 . . . . 0.0 104.597 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 80' ' ' SER . . . -81.8 58.68 4.9 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.887 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 122.382 1.087 . . . . 0.0 111.639 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 m -67.9 123.52 20.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.039 0.493 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.88 87.49 5.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.031 0.832 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.61 -169.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.707 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.11 36.45 91.92 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 53.27 89.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.904 1.002 . . . . 0.0 113.326 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -79.79 179.18 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.795 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.73 161.19 21.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.681 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.9 pt-20 -160.69 23.7 0.15 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.082 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.681 ' HD2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -145.66 -116.86 0.08 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.057 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.78 8.6 24.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 41.1 mt-10 -78.97 159.06 27.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.996 1.379 . . . . 0.0 114.682 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -91.02 113.89 26.28 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 110.983 -2.826 . . . . 0.0 112.233 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -79.94 127.4 32.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.5 t -68.34 173.7 4.64 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.407 1.099 . . . . 0.0 111.858 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 37.8 tt0 -73.04 -28.45 62.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.2 t70 -78.76 -19.78 51.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 111.745 -2.479 . . . . 0.0 106.79 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 99.39 -11.89 61.62 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -64.99 115.66 5.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 51.0 t -83.4 129.02 34.97 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.545 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -136.86 151.84 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -84.28 172.85 11.47 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.747 0.655 . . . . 0.0 112.479 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' HA ' HG22 ' A' ' 26' ' ' VAL . 48.1 m-85 -57.79 -37.16 73.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.529 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 11.3 mptt -54.2 -22.91 12.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.416 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.569 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.2 m95 -89.05 -32.99 17.3 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.286 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 21' ' ' ILE . 16.4 m -77.34 149.96 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t 35.98 41.94 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 112.314 -2.221 . . . . 0.0 113.734 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.36 -39.02 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.175 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.24 -4.91 1.18 Allowed Glycine 0 N--CA 1.48 1.593 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 t -139.62 168.02 20.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.122 0.963 . . . . 0.0 111.051 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.67 113.26 25.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.295 -1.775 . . . . 0.0 108.944 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -90.62 -23.21 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.727 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 44.4 t -77.86 -20.23 53.42 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.899 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 75.34 39.31 0.37 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.09 -50.29 0.39 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.221 -1.808 . . . . 0.0 107.278 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 113.09 -0.6 25.48 Favored Glycine 0 C--O 1.21 -1.365 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 36.3 t -49.96 -59.29 4.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.806 0.945 . . . . 0.0 109.667 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.02 -17.84 62.67 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.112 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.64 1.31 25.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 125.006 1.441 . . . . 0.0 112.907 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 42.6 t -93.98 36.8 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 60.28 -11.37 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -44.35 -33.43 1.63 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 121.05 1.75 . . . . 0.0 112.277 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.2 p -102.68 -121.21 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.062 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t 57.78 23.24 9.36 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.457 1.903 . . . . 0.0 110.394 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 49' ' ' CYS . 67.6 mt -79.53 -79.81 0.13 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.446 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m 37.6 -103.91 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 48' ' ' THR . 17.7 m -49.44 -104.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.169 0.987 . . . . 0.0 113.525 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 ' H ' HG23 ' A' ' 47' ' ' VAL . 4.9 t -84.57 62.25 7.18 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 55' ' ' SER . 24.5 p -55.15 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 53.11 23.28 2.94 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 123.646 1.689 . . . . 0.0 109.086 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.1 t 60.21 61.81 1.74 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 111.55 -2.568 . . . . 0.0 114.557 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.08 34.71 2.1 Favored Glycine 0 N--CA 1.503 3.154 0 CA-C-N 113.068 -1.878 . . . . 0.0 116.683 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.32 -158.37 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.675 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 8.8 t80 -127.07 94.05 3.92 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.211 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.61 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.2 t -68.94 118.79 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.7 m -54.59 -47.6 73.16 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.125 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.75 -156.29 27.93 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.157 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 -27.36 18.72 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 60' ' ' VAL . 36.9 ptt-85 -59.51 -46.7 88.08 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 34.5 m -134.64 134.23 54.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -106.61 89.67 3.1 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.857 1.313 . . . . 0.0 108.857 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -150.09 119.28 6.78 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.238 -2.256 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.9 m -79.61 127.97 32.82 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.111 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 41.3 mm -103.7 138.13 19.44 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.577 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 37.0 Cg_exo -52.81 126.59 21.7 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 107.811 -1.65 . . . . 0.0 107.811 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -48.21 -40.36 24.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -62.11 -10.3 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.38 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.4 ' CE2' ' HG2' ' A' ' 65' ' ' PRO . 26.5 m0 -78.84 8.52 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -82.27 129.87 34.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 13.7 t 57.84 37.17 26.94 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.96 1.362 . . . . 0.0 107.945 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.25 0.64 53.33 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.72 -28.64 0.9 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.418 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -100.48 105.97 17.47 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.55 125.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 124.035 0.835 . . . . 0.0 111.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -114.56 -39.66 3.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.646 ' SG ' ' CE2' ' A' ' 54' ' ' PHE . 77.6 m -92.29 141.59 28.39 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.367 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 59' ' ' ARG . 25.0 t70 -58.46 -45.45 88.59 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 123.588 0.555 . . . . 0.0 111.705 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -66.95 -14.02 62.41 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.868 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 59.55 27.69 63.99 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.298 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 m -72.72 21.45 0.07 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 19.2 p-10 -128.14 2.89 5.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.813 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.53 -59.85 0.72 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.87 -38.62 64.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.85 16.77 0.77 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.737 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 122.443 1.116 . . . . 0.0 112.261 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -72.78 96.0 1.99 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.161 -0.52 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.04 56.05 7.27 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.529 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.08 150.41 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.304 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.83 -13.04 3.91 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.24 36.18 0.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.451 -0.874 . . . . 0.0 111.297 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -93.68 -167.99 1.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.721 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 63.9 m -145.69 173.91 11.66 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.27 45.32 0.97 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -141.5 -118.75 0.11 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.219 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.74 5.48 36.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 38.9 mt-10 -82.76 156.82 23.51 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.693 1.235 . . . . 0.0 113.758 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CD1' HG21 ' A' ' 43' ' ' THR . 83.6 t80 -94.34 115.35 27.56 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 111.644 -2.526 . . . . 0.0 113.055 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.31 133.3 36.63 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.6 t -73.89 176.05 6.75 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.205 1.002 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 33.8 tt0 -73.67 -31.06 63.26 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 101.834 -3.395 . . . . 0.0 101.834 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.29 -19.07 59.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 112.374 -2.194 . . . . 0.0 107.126 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 15' ' ' CYS . . . 100.36 -14.24 59.59 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.6 117.33 7.24 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.69 -0.755 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 22.7 t -81.86 129.56 34.79 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -137.69 150.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.3 m -82.55 170.81 14.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.707 0.629 . . . . 0.0 112.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . 9.1 m-85 -60.48 -34.68 74.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.772 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -55.62 -22.13 21.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.5 m95 -87.1 -31.1 20.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.542 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 23' ' ' TYR . 32.9 m -75.01 149.03 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 118.481 -1.287 . . . . 0.0 113.155 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.34 41.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.744 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -89.35 8.09 32.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.79 -16.69 43.28 Favored Glycine 0 N--CA 1.486 2.032 0 O-C-N 124.012 0.82 . . . . 0.0 113.565 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -139.43 170.16 16.44 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.509 0.671 . . . . 0.0 110.986 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.11 111.44 23.83 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.625 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.7 mp0 -87.42 -23.49 24.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.6 t -78.52 -15.82 58.17 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 123.82 0.7 . . . . 0.0 110.336 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.85 43.26 3.15 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -141.25 -53.48 0.46 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.74 -8.15 17.13 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -44.13 -58.68 2.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.997 1.057 . . . . 0.0 113.473 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 1.8 p30 -63.51 -25.1 68.1 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.668 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -97.75 0.96 47.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 125.069 1.48 . . . . 0.0 110.989 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.7 t -96.52 34.67 1.6 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.314 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 29.66 57.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.399 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -85.42 -37.62 19.59 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.249 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 13' ' ' PHE . 5.6 t -122.5 -6.73 8.68 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.785 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 28.9 t -63.25 -5.47 3.4 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.313 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -83.38 31.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.778 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.9 m -142.89 -65.45 0.39 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.98 84.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 124.347 1.029 . . . . 0.0 110.361 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m 49.9 69.03 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 27.9 p -64.2 167.21 6.87 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.754 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -170.26 90.26 0.17 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.789 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.3 t -162.36 52.62 0.21 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.65 32.09 58.19 Favored Glycine 0 N--CA 1.498 2.798 0 CA-C-N 113.459 -1.7 . . . . 0.0 113.386 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -97.34 156.98 16.2 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.081 0.943 . . . . 0.0 111.889 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 81' ' ' ASP . 30.7 t80 -84.54 87.83 7.28 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.228 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.6 p -76.39 111.45 11.86 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 62' ' ' ARG . 56.8 m -48.84 -45.69 41.07 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.42 -174.63 0.2 Allowed Glycine 0 N--CA 1.489 2.178 0 CA-C-N 113.35 -1.75 . . . . 0.0 115.045 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.3 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 CA-C-N 113.011 -1.595 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -66.48 -41.75 88.52 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.059 -1.07 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.81 138.14 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 123.639 0.587 . . . . 0.0 110.158 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -94.79 65.11 2.99 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HE ' ' N ' ' A' ' 63' ' ' CYS . 6.0 tpm_? -104.6 115.85 31.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.735 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.556 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 77.9 m -79.23 118.07 20.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 ' SG ' ' A' ' 76' ' ' CYS . 29.0 mm -108.78 128.58 25.25 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.442 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 17.8 Cg_endo -61.07 146.31 97.84 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 107.11 -1.919 . . . . 0.0 107.11 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.98 -36.96 65.94 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.82 -24.07 1.31 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.753 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.446 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 46.6 m0 -107.6 42.03 1.41 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -123.11 120.04 32.07 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 33.2 t 64.5 50.67 2.15 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 127.497 2.319 . . . . 0.0 108.903 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -109.4 2.76 20.84 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.185 -2.28 . . . . 0.0 111.649 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.05 -41.22 2.73 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -79.95 104.96 10.88 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.44 0.638 . . . . 0.0 112.698 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.08 142.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.36 -39.13 2.22 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.505 -2.134 . . . . 0.0 107.538 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 64' ' ' ILE . 89.1 m -79.53 158.33 27.22 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.102 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.24 -65.07 0.63 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.413 1.07 . . . . 0.0 109.862 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -83.95 -8.98 59.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.687 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 65.22 44.42 93.85 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.056 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -75.67 33.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 17.1 p-10 -118.97 -37.63 3.19 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.192 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.36 -52.01 3.48 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -73.54 -41.72 62.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.847 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.35 -6.01 56.53 Favored Glycine 0 N--CA 1.487 2.064 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.359 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 122.241 1.02 . . . . 0.0 112.006 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 m -72.6 94.82 1.76 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.129 0.546 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.92 2.84 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.14 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.6 173.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.76 37.44 34.18 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.29 109.1 5.1 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.376 0.608 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.6 ptt85 -103.45 -170.33 1.77 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.235 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . 94.1 m -119.86 172.02 8.01 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.2 pt-20 -145.77 42.47 1.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -137.92 -118.18 0.15 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.229 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.99 11.27 35.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 39.4 mt-10 -90.16 156.93 18.0 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.381 1.086 . . . . 0.0 113.047 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -91.9 114.25 26.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.139 -2.301 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -80.48 131.28 35.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 47.6 t -73.44 175.1 7.29 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.25 1.024 . . . . 0.0 111.072 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.494 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 48.4 tt0 -73.77 -30.17 62.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 14.6 t70 -73.56 -21.35 60.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.784 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.88 62.05 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.37 118.94 12.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.467 -0.867 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' GLU . 22.9 t -84.53 134.47 34.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.56 152.24 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 66.6 m -83.0 170.76 14.55 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.768 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 26' ' ' VAL . 16.7 m-85 -60.57 -36.06 77.57 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.192 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -54.7 -23.17 16.34 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.454 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.56 ' HB2' HD13 ' A' ' 21' ' ' ILE . 6.3 m95 -84.35 -33.89 23.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 23' ' ' TYR . 26.5 m -73.55 140.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t 41.59 50.64 3.82 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 111.851 -2.431 . . . . 0.0 113.672 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -85.1 -39.54 17.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.88 -29.53 0.32 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.057 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 p -125.18 171.81 10.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.78 117.98 32.23 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -92.51 -22.04 19.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.75 0.656 . . . . 0.0 111.776 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 17' ' ' ASP . 37.6 t -78.1 -20.96 51.22 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.158 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 76.78 30.39 0.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 125.821 1.95 . . . . 0.0 108.326 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.8 -52.39 0.99 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 112.439 -2.164 . . . . 0.0 106.814 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 120.98 -5.6 11.23 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 32.7 t -45.76 -60.16 2.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.933 1.019 . . . . 0.0 111.886 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 26' ' ' VAL . 1.9 p30 -63.55 -22.81 67.1 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.657 -1.61 . . . . 0.0 111.84 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -100.48 1.01 40.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.013 1.446 . . . . 0.0 112.016 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 36' ' ' GLY . 34.4 t -86.17 38.97 0.79 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 42.45 24.31 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.21 -40.57 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 t -148.02 89.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.008 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 t -125.68 1.14 7.5 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.139 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.4 mm? -78.8 -19.42 52.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.862 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -65.9 158.01 29.11 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.92 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' H ' ' A' ' 48' ' ' THR . 11.2 p 37.67 -123.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 124.762 1.289 . . . . 0.0 111.644 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 47' ' ' VAL . 98.4 m -92.36 101.92 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.64 -172.75 1.96 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.176 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -168.02 76.1 0.13 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -149.94 40.23 0.8 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.911 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.86 5.27 3.95 Favored Glycine 0 N--CA 1.501 3.008 0 CA-C-N 114.407 -1.269 . . . . 0.0 115.779 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.0 177.86 8.63 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 117.34 0.57 . . . . 0.0 111.264 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 56.6 t80 -78.2 164.16 25.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.458 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 54' ' ' PHE . 74.2 p -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -67.46 -46.68 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.46 -168.0 0.37 Allowed Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.854 1.346 . . . . 0.0 115.419 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.63 -100.5 0.04 OUTLIER Glycine 0 N--CA 1.499 2.87 0 CA-C-N 114.141 -1.029 . . . . 0.0 112.257 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 76' ' ' CYS . 32.2 ptt-85 -48.03 -38.29 16.88 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.171 -1.015 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.68 -159.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 124.012 0.82 . . . . 0.0 109.049 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -154.58 95.36 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -166.37 128.67 1.87 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.69 137.22 36.3 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.952 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG13 ' SG ' ' A' ' 76' ' ' CYS . 35.8 mm -118.2 131.78 24.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HG2' ' CD2' ' A' ' 68' ' ' TRP . 7.3 Cg_endo -53.99 145.6 51.48 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -56.56 -32.66 65.39 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 118.648 -1.221 . . . . 0.0 107.999 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.66 -24.08 20.14 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.975 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.523 ' CD2' ' HG2' ' A' ' 65' ' ' PRO . 47.5 m0 -108.83 38.09 2.36 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 70' ' ' CYS . 1.2 tmt_? -124.17 124.5 42.61 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 36.1 t 58.34 48.67 12.08 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.795 1.638 . . . . 0.0 108.434 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -103.06 7.12 38.97 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 111.773 -2.467 . . . . 0.0 113.728 -179.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 82' ' ' GLU . . . 79.38 -29.16 2.26 Favored Glycine 0 CA--C 1.55 2.224 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 71' ' ' ASP . 19.7 tt0 -103.79 106.51 17.04 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.828 0.823 . . . . 0.0 112.354 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' HA2' ' A' ' 79' ' ' GLY . 73.5 t -62.82 140.93 18.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.601 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.56 -34.69 4.18 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.7 -2.046 . . . . 0.0 108.161 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' A' ' 54' ' ' PHE . 88.8 m -79.82 164.37 23.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.149 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.22 -60.36 3.39 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 43.3 t30 -80.95 -51.14 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 110.84 41.57 1.19 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.3 t -75.47 29.56 0.1 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.248 1.499 . . . . 0.0 112.947 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 79' ' ' GLY . 1.9 p30 -111.39 -37.74 5.17 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.097 -2.32 . . . . 0.0 105.631 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -102.23 -53.49 2.9 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.84 -41.06 79.03 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.09 28.79 6.97 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 111.941 -2.391 . . . . 0.0 112.762 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 123.095 1.426 . . . . 0.0 110.513 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.0 m -69.45 136.09 51.07 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.913 0.419 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.87 157.83 35.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.976 0.797 . . . . 0.0 110.638 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.64 179.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.926 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.46 -0.66 47.82 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.85 70.96 9.95 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.668 -0.766 . . . . 0.0 110.843 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.53 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -78.59 176.2 9.67 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.585 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . 77.6 m -121.52 175.86 5.98 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.068 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' H ' ' HD2' ' A' ' 10' ' ' ARG . 11.0 pt-20 -148.06 43.44 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -139.53 -118.01 0.13 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.626 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 6.0 p30 -100.47 1.38 41.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . 40.6 mt-10 -79.47 157.88 27.39 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.892 0.853 . . . . 0.0 111.258 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -90.41 114.1 26.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.197 -1.819 . . . . 0.0 112.129 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.3 133.32 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 16' ' ' GLN . 48.9 t -72.49 176.19 5.61 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.257 1.027 . . . . 0.0 111.327 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 10.4 tp-100 -74.53 -29.83 61.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 101.946 -3.353 . . . . 0.0 101.946 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.88 -18.64 58.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.446 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.72 63.63 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -65.87 120.11 12.48 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.509 -0.846 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 12' ' ' GLU . 27.7 t -82.4 133.68 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 25' ' ' TRP . 2.8 pp -141.76 153.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 70.6 m -88.76 176.2 7.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 26' ' ' VAL . 8.3 m-85 -59.87 -33.38 71.73 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.386 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 12.0 mptt -63.06 -21.71 66.35 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HB2' HD13 ' A' ' 21' ' ' ILE . 7.8 m95 -86.73 -20.03 28.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.804 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 23' ' ' TYR . 28.4 m -93.73 150.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.545 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.3 t 49.95 34.39 7.94 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.074 -1.876 . . . . 0.0 115.676 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -93.97 20.67 7.51 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.37 -8.55 25.16 Favored Glycine 0 N--CA 1.487 2.075 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.028 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -125.61 168.77 13.24 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.366 0.603 . . . . 0.0 111.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 116.34 31.5 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.08 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 11.3 mp0 -96.13 -24.62 16.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.107 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.6 t -78.48 -11.75 59.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 63.08 34.47 13.74 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.03 -53.02 0.91 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 40' ' ' SER . . . 108.96 0.63 31.83 Favored Glycine 0 C--O 1.21 -1.392 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -52.81 -55.99 18.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.764 0.92 . . . . 0.0 110.392 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' VAL . 2.4 p30 -60.68 -15.12 25.51 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.982 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -117.46 1.94 12.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.829 1.331 . . . . 0.0 112.439 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.7 t -88.63 29.46 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.187 0.994 . . . . 0.0 113.017 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 68.37 -0.25 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.46 -30.78 1.49 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -151.63 32.42 0.56 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.56 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.9 t -89.34 22.18 3.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.049 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -105.2 -31.16 9.25 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.612 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 p -88.73 -112.31 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.607 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.84 139.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.227 0.329 . . . . 0.0 111.687 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t 35.1 46.95 0.25 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 125.033 1.458 . . . . 0.0 113.095 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 27.4 p -58.4 165.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.982 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -164.13 88.83 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.998 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -171.66 49.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.91 35.86 64.87 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -79.32 164.48 24.05 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.855 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 56.1 t80 -103.51 103.53 13.5 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.693 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.8 p -86.84 118.7 26.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.4 m -46.14 -55.42 7.05 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.4 -170.16 43.08 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.787 -1.197 . . . . 0.0 113.718 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.44 -30.79 66.38 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 60' ' ' VAL . 16.0 ptm180 -61.68 -45.38 94.25 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.427 HG22 ' HG3' ' A' ' 59' ' ' ARG . 35.3 m -139.92 115.69 8.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.11 46.72 1.04 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.415 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -94.02 125.31 38.57 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.871 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.9 141.55 37.52 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.259 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 54' ' ' PHE . 25.6 mm -131.72 145.12 56.13 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.5 134.75 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 107.098 -1.924 . . . . 0.0 107.098 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -53.24 -35.21 59.74 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -65.65 -9.46 27.51 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.191 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -79.0 0.19 28.65 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -80.97 143.66 32.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t 50.33 33.15 7.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.28 0.987 . . . . 0.0 108.628 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -91.57 2.37 56.49 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 -18.63 0.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -105.58 102.45 11.91 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 117.58 0.69 . . . . 0.0 112.811 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.87 134.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.356 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -124.05 -40.5 2.28 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.797 -2.001 . . . . 0.0 107.077 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -81.05 167.49 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.751 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.56 -62.01 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.684 0.615 . . . . 0.0 110.301 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.6 p30 -86.46 -8.35 57.68 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' ASP . . . 66.73 51.1 43.53 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 39.8 p -69.23 8.1 0.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.236 -0.982 . . . . 0.0 112.103 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 18.8 p-10 -118.02 8.15 12.42 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.482 1.513 . . . . 0.0 109.694 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.57 -62.32 1.32 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -65.6 -34.66 78.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . -46.69 -14.7 0.12 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-N 110.836 -2.893 . . . . 0.0 117.221 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 122.137 0.97 . . . . 0.0 112.991 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_